JPH07121933B2 - Dihydrobenzofuranone derivative - Google Patents
Dihydrobenzofuranone derivativeInfo
- Publication number
- JPH07121933B2 JPH07121933B2 JP7413188A JP7413188A JPH07121933B2 JP H07121933 B2 JPH07121933 B2 JP H07121933B2 JP 7413188 A JP7413188 A JP 7413188A JP 7413188 A JP7413188 A JP 7413188A JP H07121933 B2 JPH07121933 B2 JP H07121933B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- mixture
- dimethyl
- water
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- HNLCHTDBSOPEMY-UHFFFAOYSA-N 3a,4-dihydro-3h-1-benzofuran-2-one Chemical class C1C=CC=C2OC(=O)CC21 HNLCHTDBSOPEMY-UHFFFAOYSA-N 0.000 title claims description 8
- -1 2-oxo-1-pyrrolidinyl group Chemical group 0.000 claims description 61
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 12
- 125000003277 amino group Chemical group 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- 125000004442 acylamino group Chemical group 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 2
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000004076 pyridyl group Chemical group 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 70
- 239000000203 mixture Substances 0.000 description 69
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 66
- 150000001875 compounds Chemical class 0.000 description 61
- 229910052739 hydrogen Inorganic materials 0.000 description 58
- 239000000243 solution Substances 0.000 description 56
- 239000002904 solvent Substances 0.000 description 51
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 48
- 238000000921 elemental analysis Methods 0.000 description 48
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 46
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 42
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 41
- 238000002844 melting Methods 0.000 description 40
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
- 230000008018 melting Effects 0.000 description 39
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 36
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 36
- 238000006243 chemical reaction Methods 0.000 description 33
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 32
- 238000003756 stirring Methods 0.000 description 27
- 238000010992 reflux Methods 0.000 description 25
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 20
- 238000001816 cooling Methods 0.000 description 19
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
- 239000011541 reaction mixture Substances 0.000 description 18
- 235000017557 sodium bicarbonate Nutrition 0.000 description 18
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 18
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 14
- 238000003818 flash chromatography Methods 0.000 description 14
- 239000000741 silica gel Substances 0.000 description 14
- 229910002027 silica gel Inorganic materials 0.000 description 14
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 14
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 13
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 12
- 238000001704 evaporation Methods 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 12
- RWOFWLWBVARJBU-UHFFFAOYSA-N 3-(2,2-dimethyl-3-oxo-1-benzofuran-5-yl)prop-2-enoic acid Chemical compound CC1(OC2=C(C1=O)C=C(C=C2)C=CC(=O)O)C RWOFWLWBVARJBU-UHFFFAOYSA-N 0.000 description 10
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 10
- 208000000718 duodenal ulcer Diseases 0.000 description 10
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 8
- 239000005457 ice water Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- SPWVRYZQLGQKGK-UHFFFAOYSA-N dichloromethane;hexane Chemical compound ClCCl.CCCCCC SPWVRYZQLGQKGK-UHFFFAOYSA-N 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 6
- 239000012044 organic layer Substances 0.000 description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- YOCIJWAHRAJQFT-UHFFFAOYSA-N 2-bromo-2-methylpropanoyl bromide Chemical compound CC(C)(Br)C(Br)=O YOCIJWAHRAJQFT-UHFFFAOYSA-N 0.000 description 5
- 208000007107 Stomach Ulcer Diseases 0.000 description 5
- 206010042220 Stress ulcer Diseases 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- NPOMSUOUAZCMBL-UHFFFAOYSA-N dichloromethane;ethoxyethane Chemical compound ClCCl.CCOCC NPOMSUOUAZCMBL-UHFFFAOYSA-N 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 229940124597 therapeutic agent Drugs 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 231100000053 low toxicity Toxicity 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- WTSVQDPGKCEXAU-UHFFFAOYSA-N 2,2,5-trimethyl-1-benzofuran-3-one Chemical compound CC1=CC=C2OC(C)(C)C(=O)C2=C1 WTSVQDPGKCEXAU-UHFFFAOYSA-N 0.000 description 3
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- OQNGCCWBHLEQFN-UHFFFAOYSA-N chloroform;hexane Chemical compound ClC(Cl)Cl.CCCCCC OQNGCCWBHLEQFN-UHFFFAOYSA-N 0.000 description 3
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 201000005917 gastric ulcer Diseases 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000002198 insoluble material Substances 0.000 description 3
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- CHLICZRVGGXEOD-UHFFFAOYSA-N 1-Methoxy-4-methylbenzene Chemical compound COC1=CC=C(C)C=C1 CHLICZRVGGXEOD-UHFFFAOYSA-N 0.000 description 2
- RESPXSHDJQUNTN-UHFFFAOYSA-N 1-piperidin-1-ylprop-2-en-1-one Chemical compound C=CC(=O)N1CCCCC1 RESPXSHDJQUNTN-UHFFFAOYSA-N 0.000 description 2
- UDBSFZDEEWPXHU-UHFFFAOYSA-N 2,2,6-trimethyl-1-benzofuran-3-one Chemical compound CC1=CC=C2C(=O)C(C)(C)OC2=C1 UDBSFZDEEWPXHU-UHFFFAOYSA-N 0.000 description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- FTYMJPNQPCWPAL-UHFFFAOYSA-N 2-methyl-2-(2-methylphenoxy)propanoic acid Chemical compound CC1=CC=CC=C1OC(C)(C)C(O)=O FTYMJPNQPCWPAL-UHFFFAOYSA-N 0.000 description 2
- SURFMLIOSFSAPK-UHFFFAOYSA-N 2-methyl-2-(3-methylphenoxy)propanoic acid Chemical compound CC1=CC=CC(OC(C)(C)C(O)=O)=C1 SURFMLIOSFSAPK-UHFFFAOYSA-N 0.000 description 2
- NILZESHMDJTOEV-UHFFFAOYSA-N 3-(2,4-dimethoxyphenyl)-1-piperidin-1-ylprop-2-en-1-one Chemical compound COC1=CC(OC)=CC=C1C=CC(=O)N1CCCCC1 NILZESHMDJTOEV-UHFFFAOYSA-N 0.000 description 2
- ACZGCWSMSTYWDQ-UHFFFAOYSA-N 3h-1-benzofuran-2-one Chemical compound C1=CC=C2OC(=O)CC2=C1 ACZGCWSMSTYWDQ-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000012954 diazonium Substances 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-O diazynium Chemical compound [NH+]#N IJGRMHOSHXDMSA-UHFFFAOYSA-O 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- GCFHZZWXZLABBL-UHFFFAOYSA-N ethanol;hexane Chemical compound CCO.CCCCCC GCFHZZWXZLABBL-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical compound CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- COIOYMYWGDAQPM-UHFFFAOYSA-N tris(2-methylphenyl)phosphane Chemical compound CC1=CC=CC=C1P(C=1C(=CC=CC=1)C)C1=CC=CC=C1C COIOYMYWGDAQPM-UHFFFAOYSA-N 0.000 description 2
- TXTWXQXDMWILOF-UHFFFAOYSA-N (2-ethoxy-2-oxoethyl)azanium;chloride Chemical compound [Cl-].CCOC(=O)C[NH3+] TXTWXQXDMWILOF-UHFFFAOYSA-N 0.000 description 1
- YIKHDPHTFYWYJV-GQCTYLIASA-N (e)-3-(2,4-dimethoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C(OC)=C1 YIKHDPHTFYWYJV-GQCTYLIASA-N 0.000 description 1
- HJORCZCMNWLHMB-UHFFFAOYSA-N 1-(3-aminopropyl)pyrrolidin-2-one Chemical compound NCCCN1CCCC1=O HJORCZCMNWLHMB-UHFFFAOYSA-N 0.000 description 1
- MGKPCLNUSDGXGT-UHFFFAOYSA-N 1-benzofuran-3-one Chemical compound C1=CC=C2C(=O)COC2=C1 MGKPCLNUSDGXGT-UHFFFAOYSA-N 0.000 description 1
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 1
- LBGDPMJUIZPQEE-UHFFFAOYSA-N 2,2,4-trimethyl-1-benzofuran-3-one Chemical compound Cc1cccc2OC(C)(C)C(=O)c12 LBGDPMJUIZPQEE-UHFFFAOYSA-N 0.000 description 1
- SAYHBUQZHPWWJD-UHFFFAOYSA-N 2,2,7-trimethyl-1-benzofuran-3-one Chemical compound CC1=CC=CC2=C1OC(C)(C)C2=O SAYHBUQZHPWWJD-UHFFFAOYSA-N 0.000 description 1
- LCSWYQZBXHMMQH-UHFFFAOYSA-N 2,2-dimethyl-5-(3-morpholin-4-yl-3-oxoprop-1-enyl)-1-benzofuran-3-one Chemical compound CC1(OC2=C(C1=O)C=C(C=C2)C=CC(=O)N1CCOCC1)C LCSWYQZBXHMMQH-UHFFFAOYSA-N 0.000 description 1
- WOXFMYVTSLAQMO-UHFFFAOYSA-N 2-Pyridinemethanamine Chemical compound NCC1=CC=CC=N1 WOXFMYVTSLAQMO-UHFFFAOYSA-N 0.000 description 1
- LVGHBHBZMHIHNU-UHFFFAOYSA-N 3-morpholin-4-yl-3-oxopropanoic acid Chemical compound OC(=O)CC(=O)N1CCOCC1 LVGHBHBZMHIHNU-UHFFFAOYSA-N 0.000 description 1
- 229940077398 4-methyl anisole Drugs 0.000 description 1
- UZOFELREXGAFOI-UHFFFAOYSA-N 4-methylpiperidine Chemical compound CC1CCNCC1 UZOFELREXGAFOI-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 206010058667 Oral toxicity Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- BAPJBEWLBFYGME-UHFFFAOYSA-N acrylic acid methyl ester Natural products COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical class COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 1
- RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- QSKWJTXWJJOJFP-UHFFFAOYSA-N chloroform;ethoxyethane Chemical compound ClC(Cl)Cl.CCOCC QSKWJTXWJJOJFP-UHFFFAOYSA-N 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 1
- NLIFMAOINVWKNL-UHFFFAOYSA-N ethyl 1-benzofuran-5-carboxylate Chemical compound CCOC(=O)C1=CC=C2OC=CC2=C1 NLIFMAOINVWKNL-UHFFFAOYSA-N 0.000 description 1
- NTNZTEQNFHNYBC-UHFFFAOYSA-N ethyl 2-aminoacetate Chemical compound CCOC(=O)CN NTNZTEQNFHNYBC-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 150000002690 malonic acid derivatives Chemical class 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- OPFJHFOFMZFPKX-UHFFFAOYSA-N methyl 3-(2,4-dimethoxyphenyl)prop-2-enoate Chemical compound COC(=O)C=CC1=CC=C(OC)C=C1OC OPFJHFOFMZFPKX-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- ZIYVHBGGAOATLY-UHFFFAOYSA-N methylmalonic acid Chemical compound OC(=O)C(C)C(O)=O ZIYVHBGGAOATLY-UHFFFAOYSA-N 0.000 description 1
- 229940088644 n,n-dimethylacrylamide Drugs 0.000 description 1
- 230000000802 nitrating effect Effects 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 231100000418 oral toxicity Toxicity 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- RIBFXMJCUYXJDZ-UHFFFAOYSA-N propanoyl bromide Chemical compound CCC(Br)=O RIBFXMJCUYXJDZ-UHFFFAOYSA-N 0.000 description 1
- HDOUGSFASVGDCS-UHFFFAOYSA-N pyridin-3-ylmethanamine Chemical compound NCC1=CC=CN=C1 HDOUGSFASVGDCS-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910001494 silver tetrafluoroborate Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は医薬品として有用なジヒドロベンゾフラノン誘
導体に関するものである。DETAILED DESCRIPTION OF THE INVENTION [Industrial field of use] The present invention relates to a dihydrobenzofuranone derivative useful as a drug.
さらに詳しく述べれば、本発明は胃、十二指腸潰瘍治療
剤として有用な、一般式 (式中のR1およびR2は同じでも異なっていてもよく、そ
れぞれ水素原子または置換基として低級アルコキシカル
ボニル基、2−オキソ−1−ピロリジニル基またはピリ
ジル基を有することもある低級アルキル基であるか、あ
るいは−NR1R2が一体となって1−ピロリジニル基、ピ
ペリジノ基、4−メチルピペリジノ基、モルホリノ基ま
たは1−ペルヒドロアゼピニル基を形成するものであ
り、R3およびR4は水素原子または低級アルキル基であ
り、Yは水素原子、ニトロ基、アミノ基、低級アシルア
ミノ基、低級アルキル基、低級アルコキシ基または低級
アルコキシカルボニル基である)で表されるジヒドロベ
ンゾフラノン誘導体を提供するものである。More specifically, the present invention provides a compound of the general formula useful as a therapeutic agent for stomach and duodenal ulcer. (In the formula, R 1 and R 2 may be the same or different and each is a hydrogen atom or a lower alkoxycarbonyl group as a substituent, a 2-oxo-1-pyrrolidinyl group or a lower alkyl group which may have a pyridyl group. Or N-R 1 R 2 together form a 1-pyrrolidinyl group, a piperidino group, a 4-methylpiperidino group, a morpholino group or a 1-perhydroazepinyl group, and R 3 and R 4 Represents a hydrogen atom or a lower alkyl group, and Y represents a hydrogen atom, a nitro group, an amino group, a lower acylamino group, a lower alkyl group, a lower alkoxy group or a lower alkoxycarbonyl group). To do.
本発明のようなジヒドロベンゾフラノン誘導体として、
既にいくつかの化合物が知られている。例えば、ジャー
ナル、 オブ ファーマシューティカル サイエンセズ
(J.Pharm.Sci.)69巻、164ページ(1980年)に、血小
板凝集抑制作用および抗炎症作用を有する化合物の代謝
物の製造中間体として、式 で表される化合物が報告されている。As the dihydrobenzofuranone derivative as in the present invention,
Some compounds are already known. For example, in Journal of Pharmaceutical Sciences (J.Pharm.Sci.) Vol. 69, p. 164 (1980), an intermediate for producing a metabolite of a compound having an inhibitory action on platelet aggregation and an anti-inflammatory action is described. The compound represented by is reported.
また、公開特許公報・昭58-135877号には、消炎、鎮
痛、解熱剤として、一般式 (式中のR11、R12、R14およびR15は水素原子または低級
アルキル基であり、R13は水素原子またはハロゲン原子
であり、nは0または1である)で表される化合物が報
告されている。In addition, Japanese Patent Laid-Open Publication No. 58-135877 discloses a general formula for anti-inflammatory, analgesic and antipyretic agents. (Wherein R 11 , R 12 , R 14 and R 15 are a hydrogen atom or a lower alkyl group, R 13 is a hydrogen atom or a halogen atom, and n is 0 or 1) It has been reported.
さらに、公告特許公報・昭59-31511号、公開特許公報・
昭54-98752号、同昭55-2623号、同昭55-64582号、同昭5
5-147271号、同昭56-5473号、同昭56-154477号および同
昭56-154478号には、胃液分泌抑制作用、消炎作用、鎮
痛作用などを有する、一般式 (式中、環Aはベンゼン環またはナフタレン環を示し、
該ベンゼン環またはナフタレン環は低級アルキル基、ニ
トロ基、ハロゲン原子、置換されていてもよいアミノ
基、置換されていてもよい水酸基、アシル基、スルファ
モイル基、カルボキシル基、低級アルコキシカルボニル
基、置換されていてもよいカルバモイル基、置換されて
いてもよいウレイド基、置換されていてもよいチオウレ
イド基、低級アルキルチオ基、低級アルキルスルフィニ
ル基、低級アルキルスルホニル基、置換されていてもよ
いアミノメチル基、シアノ基およびフェニル基の少なく
とも1個以上で置換されていてもよい)で表される化合
物が報告されている。Furthermore, published patent gazette, Sho 59-31511, published patent gazette,
54-98752, 55-2623, 55-64582, 5
5-147271, 56-5473, 56-154477 and 56-154478 have general formulas having gastric secretion inhibitory action, anti-inflammatory action, analgesic action, etc. (In the formula, ring A represents a benzene ring or a naphthalene ring,
The benzene ring or naphthalene ring is a lower alkyl group, nitro group, halogen atom, optionally substituted amino group, optionally substituted hydroxyl group, acyl group, sulfamoyl group, carboxyl group, lower alkoxycarbonyl group, substituted Optionally substituted carbamoyl group, optionally substituted ureido group, optionally substituted thioureido group, lower alkylthio group, lower alkylsulfinyl group, lower alkylsulfonyl group, optionally substituted aminomethyl group, cyano Group, which may be substituted with at least one or more of a group and a phenyl group) have been reported.
本発明者らはストレスによる潰瘍に対して有効でしかも
副作用の少ない化合物を見出すべく検討した結果、ある
種のジヒドロベンゾフラノン誘導体が実験潰瘍、特にス
トレス潰瘍に対して効果を示し、しかも毒性が少なく、
ヒトを含む哺乳動物の胃、十二指腸潰瘍治療剤として有
用であることを見出し、本発明を成すに至った。The present inventors have conducted studies to find a compound that is effective against stress-induced ulcers and has few side effects. As a result, certain dihydrobenzofuranone derivatives are effective against experimental ulcers, particularly stress ulcers, and have low toxicity. ,
The present invention was found to be useful as a therapeutic agent for gastric and duodenal ulcers of mammals including humans, and has completed the present invention.
本発明はこのような知見に基づくものである。The present invention is based on such knowledge.
本発明の前記一般式(I)で表されるジヒドロベンゾフ
ラノン誘導体はラットを用いた拘束水浸ストレス潰瘍に
対して顕著な抑制効果を示し、毒性も低く、胃、十二指
腸潰瘍治療剤として有用である。The dihydrobenzofuranone derivative represented by the above general formula (I) of the present invention shows a remarkable inhibitory effect on restraint water immersion stress ulcer in rats, has low toxicity, and is useful as a therapeutic agent for gastric and duodenal ulcers. is there.
本発明の前記一般式(I)の化合物は新規化合物であ
り、以下のようにして製造することができる。The compound of the general formula (I) of the present invention is a novel compound and can be produced as follows.
例えば、一般式 (式中のR3、R4およびYは前記と同じ意味をもつ)で表
されるカルボン酸またはその反応性官能的誘導体を一般
式 (式中のR1およびR2は前記と同じ意味をもつ)で表され
るアミノ類と反応させることにより製造することができ
る。For example, the general formula (Wherein R 3 , R 4 and Y have the same meanings as described above), a carboxylic acid represented by the general formula It can be produced by reacting with an amino compound represented by the formula (R 1 and R 2 in the formula have the same meanings as described above).
また、一般式 (式中のYは前記と同じ意味をもつ)で表される化合物
と、一般式 (式中のR1、R2、R3およびR4は前記と同じ意味をもつ)
で表されるアクリルアミド誘導体とを塩基、例えばトリ
エチルアミンの存在下、酢酸パラジウムおよびトリフェ
ニルホスィンまたはトリス(2−メチルフェニル)ホス
フィンを用いて反応させることによっても製造すること
ができる。Also, the general formula (Wherein Y has the same meaning as described above), a compound represented by the general formula (In the formula, R 1 , R 2 , R 3 and R 4 have the same meanings as described above.)
It can also be produced by reacting an acrylamide derivative represented by with palladium acetate and triphenylphosphine or tris (2-methylphenyl) phosphine in the presence of a base such as triethylamine.
さらに、一般式 (式中のR1、R2、R3、R4およびYは前記と同じ意味をも
つ)で表される化合物を塩基、例えば炭酸カリウムで処
理することによっても製造することができる。Furthermore, the general formula It can also be produced by treating a compound represented by the formula (wherein R 1 , R 2 , R 3 , R 4 and Y have the same meanings as described above) with a base such as potassium carbonate.
また、前記一般式(I)の化合物でR4が水素原子である
化合物は、一般式 (式中のYは前記と同じ意味をもつ)で表される化合物
と、一般式 (式中のR1、R2およびR3は前記と同じ意味をもつ)で表
される化合物とを反応させることによっても製造するこ
とができる。The compound of the general formula (I), wherein R 4 is a hydrogen atom, is (Wherein Y has the same meaning as described above), a compound represented by the general formula It can also be produced by reacting with a compound represented by the formula (R 1 , R 2 and R 3 in the formula have the same meanings as described above).
なお、これらの製造方法中、最初に記載した方法の場
合、一般式(II)の化合物においてYがアミノ基である
化合物は適当な保護基で保護したのち反応を行い、反応
後保護基を除去するかあるいはYがアミノ基へ変換可能
な置換基、例えばニトロ基である化合物を用いて反応を
行い、反応後アミノ基へ変換する方が好ましい。In the case of the method described first among these production methods, in the compound of the general formula (II), the compound in which Y is an amino group is protected with an appropriate protecting group and then reacted, and the protecting group is removed after the reaction. Alternatively, it is preferable to carry out the reaction using a compound in which Y is a substituent capable of converting to an amino group, for example, a nitro group, and after the reaction, convert to an amino group.
本発明の前記一般式(I)の化合物の製造原料として用
いられる前記一般式(II)、(IV)、(VI)および(VI
I)で表される化合物も新規化合物であり以下のように
して製造することができる。The general formulas (II), (IV), (VI) and (VI) used as raw materials for producing the compound of the general formula (I) of the present invention.
The compound represented by I) is also a novel compound and can be produced as follows.
例えば、一般式(II)で表される化合物は、一般式 (式中のR3、R4およびYは前記と同じ意味をもつ)で表
される化合物に無水塩化アルミニウムの存在下に2−ブ
ロモ−2−メチルプロピオニルブロミドを反応させて、
一般式 (式中のR3、R4およびYは前記と同じ意味をもつ)で表
される化合物を得、次いで塩基、例えば炭酸カリウムで
処理後エステルを加水分解することにより製造すること
ができる。For example, the compound represented by the general formula (II) is represented by the general formula 2-bromo-2-methylpropionyl bromide is reacted with a compound represented by the formula (wherein R 3 , R 4 and Y have the same meaning as described above) in the presence of anhydrous aluminum chloride,
General formula (R 3 , R 4 and Y in the formula have the same meanings as described above), and then the compound is treated with a base such as potassium carbonate and then the ester is hydrolyzed.
また、一般式(II)で表される化合物でR4が水素原子で
ある化合物は、一般式 (式中のYは前記と同じ意味をもつ)で表される化合物
を酸化剤、例えば二酸化マンガンまたは過硫酸カリウム
などを用いて酸化するかあるいはN−ブロモスクシンイ
ミドなどを用いてブロム化したのちジメチルスルホキシ
ドで酸化して、前記一般式(VII)で表されるアルデヒ
ド誘導体を得、次いでこれに、一般式 (式中のR3は前記と同じ意味をもつ)で表されるマロン
酸誘導体を反応させることにより製造することができ
る。Further, the compound represented by the general formula (II), wherein R 4 is a hydrogen atom, is The compound represented by the formula (Y has the same meaning as described above) is oxidized with an oxidizing agent such as manganese dioxide or potassium persulfate, or is brominated with N-bromosuccinimide or the like, and then dimethyl is formed. Oxidation with sulfoxide gives the aldehyde derivative represented by the general formula (VII), which is then added to the general formula It can be produced by reacting a malonic acid derivative represented by the formula (R 3 in the formula has the same meaning as described above).
本製造方法で原料として用いられる一般式(XI)の化合
物は、一般式 (式中のYは前記と同じ意味をもつ)で表されるアニソ
ール誘導体に2−ブロモ−2−メチルプロピオニルブロ
ミドを無水塩化アルミニウムの存在下に反応させて、一
般式 (式中のYは前記と同じ意味をもつ)で表される化合物
を得、これを塩基、例えば炭酸カリウムで処理するかあ
るいは、一般式 (式中のYは前記と同じ意味をもつ)で表される化合物
を酸ハロゲン化物としたのち無水塩化アルミニウムの存
在下に分子内で閉環させることにより製造することがで
きる。The compound of the general formula (XI) used as a raw material in this production method is 2-bromo-2-methylpropionyl bromide is reacted with an anisole derivative represented by the formula (Y has the same meaning as described above) in the presence of anhydrous aluminum chloride to give a compound represented by the general formula (Wherein Y has the same meaning as described above), and the compound is treated with a base such as potassium carbonate, or a compound of the general formula The compound represented by the formula (Y has the same meaning as described above) is converted into an acid halide and then ring-closed in the molecule in the presence of anhydrous aluminum chloride.
前記一般式(I)の化合物の二番目の製造方法で原料と
して用いられる一般式(IV)で表される化合物は、一般
式 (式中のYは前記と同じ意味をもつ)で表される化合物
を適当な方法でブロム化するかあるいは、一般式 (式中のYは前記と同じ意味をもつ)で表される化合物
に無水塩化アルミニウムの存在下2−ブロモ−2−メチ
ルプロピオニルブロミドを反応させ、次いで塩基で処理
することにより得ることができる。The compound represented by the general formula (IV) used as a raw material in the second production method of the compound of the general formula (I) is a compound represented by the general formula: The compound represented by the formula (Y has the same meaning as described above) is brominated by an appropriate method, or It can be obtained by reacting a compound represented by the formula (Y has the same meaning as described above) with 2-bromo-2-methylpropionyl bromide in the presence of anhydrous aluminum chloride, and then treating with a base.
さらに、得られた一般式(IV)の化合物のYを適当な処
理を加えることによって別の誘導体に変換することもで
きる。例えば、Yがメチル基である化合物を酸化してY
がカルボキシル基である化合物を得、次いでこれにエス
テル化反応を行うことによりYがアルコキシカルボニル
基である化合物に変換することができる。また、Yが水
素原子である化合物を適当な方法でニトロ化することに
よりYがニトロ基である化合物を得ることができ、これ
を還元することによりYがアミノ基である化合物に変換
することができ、さらにアミノ基を適当な方法でアシル
化することよりYがアシルアミノ基である化合物に変換
することもできる。Further, Y of the obtained compound of the general formula (IV) can be converted into another derivative by applying an appropriate treatment. For example, by oxidizing a compound in which Y is a methyl group, Y
A compound in which is a carboxyl group is obtained, and then an esterification reaction is performed on this to convert into a compound in which Y is an alkoxycarbonyl group. Further, a compound in which Y is a nitro group can be obtained by nitrating a compound in which Y is a hydrogen atom by an appropriate method, and by reducing this, a compound in which Y is an amino group can be converted. It is also possible to convert the amino group into a compound in which Y is an acylamino group by acylating the amino group by an appropriate method.
本発明の前記一般式(I)の化合物の三番目の製造方法
で出発原料として用いられる一般式(VI)の化合物は以
下のようにして製造することができる。The compound of general formula (VI) used as a starting material in the third production method of the compound of general formula (I) of the present invention can be produced as follows.
すなわち、一般式 (式中のR3、R4およびYは前記と同じ意味をもつ)で表
されるカルボン酸またはその反応性官能的誘導体とアミ
ン類(III)とを反応させて、一般式 (式中のR1、R2、R3、R4およびYは前記と同じ意味をも
つ)で表される化合物を製造し、これに無水塩化アルミ
ニウムの存在下に2−ブロモ−2−メチルプロピオニル
ブロミドを反応させることにより製造することができ
る。That is, the general formula (Wherein R 3 , R 4 and Y have the same meanings as described above), a carboxylic acid or a reactive functional derivative thereof is reacted with an amine (III) to give a compound represented by the general formula (Wherein R 1 , R 2 , R 3 , R 4 and Y have the same meanings as described above), and 2-bromo-2-methyl in the presence of anhydrous aluminum chloride is prepared. It can be produced by reacting propionyl bromide.
前記一般式(I)の化合物の四番目の製造方法で出発原
料として用いられる一般式(VII)の化合物は前に述べ
たように一般式(XI)の化合物を酸化することによって
製造することができる。The compound of the general formula (VII) used as a starting material in the fourth production method of the compound of the general formula (I) may be prepared by oxidizing the compound of the general formula (XI) as described above. it can.
さらに、得られた一般式(VII)の化合物のYに適当な
処理を加えることによって別の誘導体に変換することも
できる。例えば、Yが水素原子である化合物を適当な方
法でニトロ化することによってYがニトロ基である化合
物に変換することができる。Further, Y of the obtained compound of the general formula (VII) can be converted into another derivative by appropriate treatment. For example, a compound in which Y is a hydrogen atom can be converted into a compound in which Y is a nitro group by nitration by a suitable method.
以上のような製造中間体の製造方法に用いられる原料の
一般式(IX)、(XII)、(XIII)、(XV)、(XVI)、
(XVII)および(XVIII)で表される化合物および前記
一般式(I)の化合物のそれぞれの製造方法で上記原料
の他に出発原料として用いられる一般式(III)、
(V)および(VIII)で表される化合物は概ね公知化合
物であり、市販品として入手できるかあるいは文献記載
の方法あるいはそれらの類似方法により容易に製造する
ことができる。General formulas (IX), (XII), (XIII), (XV), (XVI) of the raw materials used in the method for producing the above-mentioned production intermediates,
In addition to the above-mentioned raw materials in the respective production methods of the compounds represented by (XVII) and (XVIII) and the compound of the general formula (I), general formula (III),
The compounds represented by (V) and (VIII) are generally known compounds, and are commercially available, or can be easily produced by a method described in the literature or a method similar thereto.
本発明の前記一般式(I)の化合物は、二重結合による
幾何異性体が存在するが、本発明においてはE体、Z体
またはその混合物のいずれかに限定するものではない。The compound of the general formula (I) of the present invention has a geometric isomer due to a double bond, but in the present invention, it is not limited to E-form, Z-form or a mixture thereof.
本発明の前記一般式(I)の化合物はウィスター系雄性
ラットを用いた拘束水浸ストレス潰瘍実験において、体
重1kg当たり100mgの経口投与で抑制率約30〜70%程度の
抗潰瘍作用を示し、ICR系雄性マウスを用いた経口単回
投与での急性毒性試験で、体重1kg当たり1000mgの投与
でも強い毒性作用は認められず、ヒトを含む哺乳動物の
胃、十二指腸潰瘍治療剤として極めて有用である。The compound of the general formula (I) of the present invention shows an anti-ulcer action with a suppression rate of about 30 to 70% by oral administration of 100 mg per 1 kg of body weight in a restrained water immersion stress ulcer experiment using Wistar male rats. In an acute single-dose oral toxicity test in male ICR mice, a strong toxic effect was not observed even at a dose of 1000 mg / kg body weight, and it is extremely useful as a therapeutic agent for stomach and duodenal ulcer in mammals including humans. .
本発明の前記一般式(I)の化合物を潰瘍治療剤として
用いる場合、単味のままあるいは適当な医薬品添加物と
混合したのち、種々の剤型に調剤して投与される。When the compound of the general formula (I) of the present invention is used as an agent for treating ulcer, it may be administered in various dosage forms as it is or after being mixed with an appropriate pharmaceutical additive.
このような剤型としては、散剤、顆粒剤、細粒剤、錠
剤、カプセル剤、シロップ剤、液剤または坐剤などのよ
うな経口投与用剤および非経口投与用剤をあげることが
できる。Examples of such dosage forms include powders, granules, fine granules, tablets, capsules, syrups, liquids, suppositories, and other oral administration agents and parenteral administration agents.
また、実際の治療に用いる場合の至適投与量は患者の年
令、体重、性別、症状の度合等によって適宜決定される
が、概ね経口投与の場合、成人1日当たり10mg〜5000m
g、非経口投与の場合、成人1日当たり1mg〜1000mgの範
囲内で1回〜数回に分けて投与される。In addition, the optimal dose for actual treatment is appropriately determined according to the patient's age, body weight, sex, degree of symptoms, etc.
In the case of parenteral administration, the daily dose for adults is from 1 mg to 1000 mg and is divided into 1 to several divided doses.
本発明の一般式(I)で表される化合物はウィスター系
雄性ラット(8週齢)を用いた拘束水浸ストレス潰瘍実
験において、体重1kg当たり100mgの経口投与で約30〜70
%程度の抑制効果を示す。The compound represented by the general formula (I) of the present invention is about 30 to 70 by oral administration of 100 mg per kg body weight in a restrained water immersion stress ulcer experiment using male Wistar rats (8 weeks old).
Shows a suppression effect of about%.
また、本発明の一般式(I)の化合物は毒性が低く、IC
R系雄性マウス(6〜7週齢)に体重1kg当たり1000mgを
経口投与した場合でもほとんど死亡例がみられない。In addition, the compound of the general formula (I) of the present invention has low toxicity and IC
Almost no deaths are observed even when 1000 mg / kg of body weight is orally administered to R male mice (6 to 7 weeks old).
このように、本発明の一般式(I)で表される化合物は
強い抗ストレス潰瘍作用を示し、しかも低毒性であるの
で、ヒトを含む哺乳動物の胃、十二指腸潰瘍治療剤とし
て有用である。As described above, the compound represented by the general formula (I) of the present invention has a strong anti-stress ulcer action and low toxicity, and is therefore useful as a therapeutic agent for stomach and duodenal ulcer of mammals including humans.
本発明の内容を以下の参考例および実施例を用いてさら
に詳細に説明する。The contents of the present invention will be described in more detail with reference to the following reference examples and examples.
なお、各参考例および実施例中の化合物の融点はすべて
未補正である。The melting points of the compounds in Reference Examples and Examples are all uncorrected.
参考例1 無水塩化アルミニウム55.0gの乾燥塩化メチレン100ml懸
濁液に氷冷撹拌下、4−メチルアニソール50mlを加えた
のち、加熱還流下に撹拌しながら2−ブロモ−2−メチ
ルプロピオニルブロミド50mlを滴下し、16時間加熱還流
させた。反応液を氷水中に注ぎ、塩酸で酸性としたの
ち、塩化メチレンで抽出し、水洗後無水硫酸マグネシウ
ムで乾燥した。減圧下に溶媒を留去し、油状の2−ブロ
モ−2′−ヒドロキシ−2,5′−ジメチルプロピオフェ
ノン101.0gを得た。Reference Example 1 50 ml of 4-methylanisole was added to 100 ml of a dry methylene chloride suspension of 55.0 g of anhydrous aluminum chloride under ice-cooling stirring, and then 50 ml of 2-bromo-2-methylpropionyl bromide was added under stirring with heating under reflux. It was added dropwise and heated under reflux for 16 hours. The reaction solution was poured into ice water, acidified with hydrochloric acid, extracted with methylene chloride, washed with water, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 101.0 g of oily 2-bromo-2'-hydroxy-2,5'-dimethylpropiophenone.
IR(neat):νCO 1630cm-1 NMR(CDCl3) δ:2.09(6H,s),2.32(3H,s),6.93(1H,d,J=8.2H
z),7.29(1H,dd,J=2.2and8.2Hz),8.26(1H,d,J=2.2
Hz),11.84(1H,s) 2−ブロモ−2′−ヒドロキシ−2,5′−ジメチルプロ
ピオフェノン100.9gを乾燥トルエン300mlに溶かし、無
水炭酸カリウム84.0gを加えたのち、撹拌下に16時間加
熱還流させた。不溶物をろ去後ろ液を水洗し、、無水硫
酸マグネシウムで乾燥後溶媒を留去し、油状の2,2,5−
トリメチル−3(2H)−ベンゾフラノン68.7gを得た。
この一部を減圧蒸留し、沸点77〜80℃/3mmHg、融点38〜
40℃の2,2,5−トリメチル−3(2H)−ベンゾフラノン
を得た。IR (neat): ν CO 1630cm -1 NMR (CDCl 3 ) δ: 2.09 (6H, s), 2.32 (3H, s), 6.93 (1H, d, J = 8.2H)
z), 7.29 (1H, dd, J = 2.2and8.2Hz), 8.26 (1H, d, J = 2.2
Hz), 11.84 (1H, s) 2-Bromo-2'-hydroxy-2,5'-dimethylpropiophenone 100.9 g was dissolved in 300 ml of dry toluene, and 84.0 g of anhydrous potassium carbonate was added, and the mixture was stirred at 16%. Heated to reflux for hours. The insoluble matter was removed by filtration, the liquid was washed with water, dried over anhydrous magnesium sulfate and the solvent was distilled off to give an oily 2,2,5-
68.7 g of trimethyl-3 (2H) -benzofuranone was obtained.
A portion of this is distilled under reduced pressure, boiling point 77-80 ℃ / 3mmHg, melting point 38-
40 ° C. 2,2,5-trimethyl-3 (2H) -benzofuranone was obtained.
元素分析値:(C11H12O2として) C% H% 計算値 74.98 6.86 実測値 74.78 6.93 IR(KBr):νCO 1715cm-1 NMR(CDCl3) δ:1.45(6H,s),2.35(3H,s),6.98(1H,d,J=8.8H
z),7.4〜7.5(2H,m) 2,2,5−トリメチル−3(2H)−ベンゾフラノン20.0gを
濃硫酸65mlと水130mlの混液に懸濁させ、二酸化マンガ
ン30.0gを加えたのち70℃で20時間撹拌した。冷後反応
液に酢酸エチルを加え、不溶物をろ去後有機層を炭酸水
素ナトリウム水溶液で洗い、無水硫酸マグネシウムで乾
燥した。減圧下に溶媒を留去し、残留物をシリカゲルフ
ラッシュカラムクロマトグラフィー(溶出溶媒:ベンゼ
ン/ヘキサン=3/1)で精製後、ジエチルエーテル−ヘ
キサンより再結晶し、融点63〜65℃の5−ホルミル−2,
2−ジメチル−3(2H)−ベンゾフラノン12.8gを得た。Elemental analysis value: (as C 11 H 12 O 2 ) C% H% Calculated value 74.98 6.86 Measured value 74.78 6.93 IR (KBr): ν CO 1715cm −1 NMR (CDCl 3 ) δ: 1.45 (6H, s), 2.35 (3H, s), 6.98 (1H, d, J = 8.8H
z), 7.4 to 7.5 (2H, m) 2,2,5-trimethyl-3 (2H) -benzofuranone 20.0 g was suspended in a mixed solution of concentrated sulfuric acid 65 ml and water 130 ml, and manganese dioxide 30.0 g was added. The mixture was stirred at 0 ° C for 20 hours. After cooling, ethyl acetate was added to the reaction solution, the insoluble material was filtered off, the organic layer was washed with an aqueous sodium hydrogen carbonate solution, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel flash column chromatography (eluting solvent: benzene / hexane = 3/1) and then recrystallized from diethyl ether-hexane to give a 5-mp melting point of 63-65 ° C. Formyl-2,
12.8 g of 2-dimethyl-3 (2H) -benzofuranone was obtained.
元素分析値:(C11H10O3として) C% H% 計算値 69.46 5.30 実測値 69.35 5.30 IR(KBr):νCO 1715,1685cm-1 NMR(CDCl3) δ:1.52(6H,s),7.21(1H,d,J=8.2Hz),8.18(1H,d,J
=2.2Hz),8.21(1H,dd,J=2.2and8.2Hz),9.96(1H,
s) 5−ホルミル−2,2−ジメチル−3(2H)−ベンゾフラ
ノン10.0gをピリジン100mlに溶かし、マロン酸11.0gと
アニリン0.2mlを加え、50℃で16時間撹拌後1時間加熱
還流させた。反応液を減圧下に濃縮したのち、塩酸で酸
性とし、析出結晶をろ取、水洗後エタノールより再結晶
し、融点194〜197℃の3-(2,3−ジヒドロ−2,2−ジメチ
ル−3−オキソ−5−ベンゾフラニル)アクリル酸8.9g
を得た。Elemental analysis value: (as C 11 H 10 O 3 ) C% H% Calculated value 69.46 5.30 Measured value 69.35 5.30 IR (KBr): ν CO 1715,1685cm −1 NMR (CDCl 3 ) δ: 1.52 (6H, s) , 7.21 (1H, d, J = 8.2Hz), 8.18 (1H, d, J
= 2.2Hz), 8.21 (1H, dd, J = 2.2and8.2Hz), 9.96 (1H,
s) 5-formyl-2,2-dimethyl-3 (2H) -benzofuranone (10.0 g) was dissolved in pyridine (100 ml), malonic acid (11.0 g) and aniline (0.2 ml) were added, and the mixture was stirred at 50 ° C for 16 hr and then refluxed for 1 hr. . The reaction solution was concentrated under reduced pressure, acidified with hydrochloric acid, the precipitated crystals were collected by filtration, washed with water and recrystallized from ethanol, and had a melting point of 194 to 197 ° C. 3- (2,3-dihydro-2,2-dimethyl- 3-oxo-5-benzofuranyl) acrylic acid 8.9 g
Got
元素分析値:(C13H12O4として) C% H% 計算値 67.23 5.21 実測値 67.33 5.19 IR(KBr):νCO 1710,1680cm-1 NMR(CDCl3) δ:1.50(6H,s),6.40(1H,d,J=15.9Hz),7.13(1H,d,
J=8.8Hz),7.78(1H,d,J=15.9Hz),7.8〜7.9(2H,m) 参考例2 5−ホルミル−2,2−ジメチル−3(2H)−ベンゾフラ
ノン0.70gを乾燥ピリジン4mlに溶かし、メチルマロン酸
0.86gおよびピペリジン0.73mlを加えたのち、48時間加
熱還流させた。反応液を減圧下に濃縮後、水を加え塩酸
で酸性としたのちクロロホルムで抽出した。この有機層
に5%水酸化ナトリウム水溶液を加えよく振り混ぜたの
ち水層を分取し、活性炭素で処理後塩酸で酸性とし、ク
ロロホルムで抽出後水洗し、無水硫酸マグネシウムで乾
燥した。減圧下に溶媒を留去後、残留物をジエチルエー
テル−ヘキサンより再結晶し、融点127〜129℃の2−メ
チル−3-(2,3−ジヒドロ−2,2−ジメチル−3−オキソ
−5−ベンゾフラニル)アクリル酸0.60gを得た。Elemental analysis value: (as C 13 H 12 O 4 ) C% H% Calculated value 67.23 5.21 Actual value 67.33 5.19 IR (KBr): ν CO 1710,1680 cm −1 NMR (CDCl 3 ) δ: 1.50 (6H, s) , 6.40 (1H, d, J = 15.9Hz), 7.13 (1H, d,
J = 8.8Hz), 7.78 (1H, d, J = 15.9Hz), 7.8-7.9 (2H, m) Reference Example 2 5-formyl-2,2-dimethyl-3 (2H) -benzofuranone 0.70g is dried with pyridine. Dissolve in 4 ml, methylmalonic acid
After adding 0.86 g and 0.73 ml of piperidine, the mixture was heated under reflux for 48 hours. The reaction mixture was concentrated under reduced pressure, water was added to acidify the mixture with hydrochloric acid, and the mixture was extracted with chloroform. An aqueous solution of 5% sodium hydroxide was added to this organic layer, and the mixture was shaken well and the aqueous layer was separated, treated with activated carbon, acidified with hydrochloric acid, extracted with chloroform, washed with water, and dried over anhydrous magnesium sulfate. After evaporating the solvent under reduced pressure, the residue was recrystallized from diethyl ether-hexane to give 2-methyl-3- (2,3-dihydro-2,2-dimethyl-3-oxo-) having a melting point of 127 to 129 ° C. 0.60 g of 5-benzofuranyl) acrylic acid was obtained.
元素分析値:(C14H14O4として) C% H% 計算値 68.28 5.73 実測値 67.96 5.69 IR(KBr):νCO 1715,1685cm-1 NMR(CDCl3) δ:1.49(6H,s),2.17(3H,d,J=1.7Hz),7.13(1H,d,J
=8.8Hz),7.70(1H,dd,J=2.2and8.8Hz),7.75〜7.85
(2H,m) 参考例3 m−クレゾール3.38gを乾燥アセトン160mlに溶かし、氷
冷撹拌下に、水酸化ナトリウム10.53gを加えたのち、乾
燥クロロホルム22mlを滴下し、室温で3時間撹拌後、2
時間加熱還流させた。反応液を減圧下に濃縮し、水を加
え塩酸で酸性としたのち、炭酸水素ナトリウムを加え中
和し、ジエチルエーテルで洗った。水層を塩酸で酸性と
したのち、クロロホルムで抽出し、水洗後無水硫酸マグ
ネシウムで乾燥した。減圧下に溶媒を留去し、油状の2
−メチル−2-(3−メチルフェノキシ)プロピオン酸4.
33gを得た。Elemental analysis value: (as C 14 H 14 O 4 ) C% H% Calculated value 68.28 5.73 Measured value 67.96 5.69 IR (KBr): ν CO 1715,1685cm −1 NMR (CDCl 3 ) δ: 1.49 (6H, s) , 2.17 (3H, d, J = 1.7Hz), 7.13 (1H, d, J
= 8.8Hz), 7.70 (1H, dd, J = 2.2and8.8Hz), 7.75 to 7.85
(2H, m) Reference Example 3 3.38 g of m-cresol was dissolved in 160 ml of dry acetone, and after adding 10.53 g of sodium hydroxide under stirring with ice cooling, 22 ml of dry chloroform was added dropwise, and after stirring at room temperature for 3 hours, Two
Heated to reflux for hours. The reaction mixture was concentrated under reduced pressure, water was added to make the mixture acidic, and the mixture was neutralized with sodium hydrogen carbonate and washed with diethyl ether. The aqueous layer was acidified with hydrochloric acid, extracted with chloroform, washed with water and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to give an oily 2
-Methyl-2- (3-methylphenoxy) propionic acid 4.
I got 33g.
IR(neat):νCO 1710cm-1 NMR(CDCl3) δ:1.60(6H,s),2.31(3H,s),6.73(1H,d,J=8.2H
z),6.76(1H,s),6.87(1H,d,J=8.2Hz),7.15(1H,t,
J=8.2Hz),8.95(1H,br) 2−メチル−2-(3−メチルフェノキシ)プロピオン酸
4.32gに乾燥ベンゼン80mlと塩化チオニル8mlを加え、2
時間加熱還流後、反応液を減圧下に濃縮乾固した。この
残留物の乾燥ベンゼン60ml溶液に、氷冷撹拌下に無水塩
化アルミニウム3.87gを加え、室温で1.5時間反応させ
た。反応液を氷水中に注ぎ、塩酸で酸性としたのちジエ
チルエーテルで抽出し、水洗後無水硫酸マグネシウムで
乾燥した。減圧下に溶媒を留去後、残留物をシリカゲル
フラッシュカラムクロマトグラフィー(溶出溶媒:グロ
ロホルム/ベンゼン=2/1)で精製し、油状の2,2,6−ト
リメチル−3(2H)−ベンゾフラノン1.28gを得た。IR (neat): ν CO 1710cm -1 NMR (CDCl 3 ) δ: 1.60 (6H, s), 2.31 (3H, s), 6.73 (1H, d, J = 8.2H)
z), 6.76 (1H, s), 6.87 (1H, d, J = 8.2Hz), 7.15 (1H, t,
J = 8.2Hz), 8.95 (1H, br) 2-methyl-2- (3-methylphenoxy) propionic acid
Add 80 ml of dry benzene and 8 ml of thionyl chloride to 4.32 g and add 2
After heating under reflux for an hour, the reaction solution was concentrated to dryness under reduced pressure. To a solution of this residue in 60 ml of dry benzene, 3.87 g of anhydrous aluminum chloride was added under ice-cooling stirring, and the mixture was reacted at room temperature for 1.5 hours. The reaction solution was poured into ice water, acidified with hydrochloric acid, extracted with diethyl ether, washed with water and dried over anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure, the residue was purified by silica gel flash column chromatography (eluting solvent: gloroform / benzene = 2/1) to obtain an oily 2,2,6-trimethyl-3 (2H) -benzofuranone 1.28. got g.
IR(neat):νCO 1710cm-1 NMR(CDCl3) δ:1.45(6H,s),2.43(3H,s),6.85〜6.95(2H,m),7.
55(1H,d,J=8.8Hz) 2,2,6−トリメチル−3(2H)−ベンゾフラノン1.26gに
乾燥四塩化炭素40ml、N−ブロモスクシンイミド1.91g
および2,2′−アゾビスイソブチロニトリル60mgを加
え、光照射撹拌下に6時間加熱還流させた。冷後反応液
を水洗し、無水硫酸マグネシウムで乾燥後、減圧下に溶
媒を留去した。残留物を乾燥ジメチルスルホキシド10ml
に溶かし、室温で撹拌下に四フッ化ホウ素酸銀1.84gを
加え、18時間反応させた。反応液に乾燥トリエチルアミ
ン0.9mlを加えたのち、氷水を加えジエチルエーテルで
抽出し、無水硫酸マグネシウムで乾燥した。減圧下に溶
媒を留去し、残留物をシリカゲルフラッシュカラムクロ
マトグラフィー(溶出溶媒:クロロホルム/ベンゼン=
2/1)で精製後、ジエチルエーテル−ヘキサンより再結
晶し、融点98〜100℃の6−ホルミル−2,2−ジメチル−
3(2H)−ベンゾフラノン0.41gを得た。IR (neat): ν CO 1710 cm -1 NMR (CDCl 3 ) δ: 1.45 (6H, s), 2.43 (3H, s), 6.85 to 6.95 (2H, m), 7.
55 (1H, d, J = 8.8Hz) 2,2,6-trimethyl-3 (2H) -benzofuranone 1.26g, dry carbon tetrachloride 40ml, N-bromosuccinimide 1.91g
And 60 mg of 2,2'-azobisisobutyronitrile were added, and the mixture was heated under reflux with stirring for 6 hours under irradiation with light. After cooling, the reaction solution was washed with water, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue is dried with dimethyl sulfoxide 10 ml
1.84 g of silver tetrafluoroborate was added with stirring at room temperature and reacted for 18 hours. After adding 0.9 ml of dry triethylamine to the reaction solution, ice water was added and the mixture was extracted with diethyl ether and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was subjected to silica gel flash column chromatography (eluting solvent: chloroform / benzene =
2/1) and then recrystallized from diethyl ether-hexane to give 6-formyl-2,2-dimethyl-mp, melting point 98-100 ° C.
0.41 g of 3 (2H) -benzofuranone was obtained.
元素分析値:(C11H10O3として) C% H% 計算値 69.46 5.30 実測値 69.29 5.27 IR(KBr):νCO 1700cm-1 NMR(CDCl3) δ:1.50(6H,s),7.55〜7.65(2H,m),7.82(1H,d,J=
8.8Hz),10.09(1H,s) 6−ホルミル−2,2−ジメチル−3(2H)−ベンゾフラ
ノン0.39gをピリジン3mlに溶かし、マロン酸0.27gとア
ニリン0.1mlを加え、60℃で18時間撹拌後、1時間加熱
還流させた。冷後反応液を氷−希塩酸中に撹拌下に加
え、析出した結晶をろ取後水洗し、融点258〜261℃の3-
(2,3−ジヒドロ−2,2−ジメチル−3−オキソ−6−ベ
ンゾフラニル)アクリル酸0.31gを得た。Elemental analysis value: (as C 11 H 10 O 3 ) C% H% Calculated value 69.46 5.30 Measured value 69.29 5.27 IR (KBr): ν CO 1700cm −1 NMR (CDCl 3 ) δ: 1.50 (6H, s), 7.55 ~ 7.65 (2H, m), 7.82 (1H, d, J =
8.8Hz), 10.09 (1H, s) 6-formyl-2,2-dimethyl-3 (2H) -benzofuranone (0.39g) is dissolved in 3ml of pyridine, 0.27g of malonic acid and 0.1ml of aniline are added, and the temperature is 60 ° C for 18 hours. After stirring, the mixture was heated to reflux for 1 hour. After cooling, the reaction solution was added to ice-diluted hydrochloric acid with stirring, and the precipitated crystals were collected by filtration and washed with water, and then the crystals with a melting point of 258 to 261 ° C.
0.31 g of (2,3-dihydro-2,2-dimethyl-3-oxo-6-benzofuranyl) acrylic acid was obtained.
元素分析値:(C13H12O4として) C% H% 計算値 67.23 5.21 実測値 67.02 5.25 IR(KBr):νCO 1695cm-1 NMR(DMSO-d6) δ:1.41(6H,S),6.73(1H,d,J=15.9Hz),7.46(1H,d,
J=7.7Hz),7.55〜7.7(3H,m),12.64(1H,br-s) 参考例4 o−クレゾール7.5gを乾燥アセトン230mlに溶かし、氷
冷撹拌下に水酸化ナトリウム27.8gを加えたのち、乾燥
クロロホルム28mlを滴下し、2時間撹拌後室温で16時間
反応させた。反応液を減圧下に濃縮し、水を加え塩酸で
酸性としたのち、炭酸水素ナトリウムを加え中和し、ジ
エチルエーテルで洗った。水層を塩酸で酸性としたの
ち、ジエチルエーテルで抽出し、水洗後無水硫酸マグネ
シウムで乾燥した。減圧下に溶媒を留去後、残留物をシ
リカゲルフラッシュカラムクロマトグラフィー(溶出溶
媒:クロロホルム/エタノール=100/1)で精製し、油
状の2−メチル−2-(2−メチルフェノキシ)プロピオ
ン酸13.0gを得た。Elemental analysis value: (as C 13 H 12 O 4 ) C% H% Calculated value 67.23 5.21 Actual value 67.02 5.25 IR (KBr): ν CO 1695cm -1 NMR (DMSO-d 6 ) δ: 1.41 (6H, S) , 6.73 (1H, d, J = 15.9Hz), 7.46 (1H, d,
J = 7.7 Hz), 7.55 to 7.7 (3H, m), 12.64 (1H, br-s) Reference Example 4 o-Cresol 7.5 g was dissolved in dry acetone 230 ml, and sodium hydroxide 27.8 g was added under ice-cooling stirring. After that, 28 ml of dry chloroform was added dropwise, and the mixture was stirred for 2 hours and reacted at room temperature for 16 hours. The reaction mixture was concentrated under reduced pressure, water was added to make the mixture acidic, and the mixture was neutralized with sodium hydrogen carbonate and washed with diethyl ether. The aqueous layer was acidified with hydrochloric acid, extracted with diethyl ether, washed with water, and dried over anhydrous magnesium sulfate. After evaporating the solvent under reduced pressure, the residue was purified by silica gel flash column chromatography (eluting solvent: chloroform / ethanol = 100/1) to give oily 2-methyl-2- (2-methylphenoxy) propionic acid 13.0. got g.
IR(neat):νCO 1710cm-1 NMR(CDCl3) δ:1.62(6H,s),2.25(3H,s),6.82(1H,d,J=7.7H
z),6.94(1H,t,J=7.7Hz),7.10(1H,t,J=7.7Hz),7.
17(1H,d,J=7.7Hz) 2−メチル−2-(2−メチルフェノキシ)プロピオン酸
11.5gに乾燥ベンゼン80mlと塩化チオニル4.3mlを加え、
2時間加熱還流させた。反応液を減圧下に濃縮乾固し、
残留物に乾燥ベンゼン80mlを加えたのち、氷冷撹拌下に
無水塩化アルミニウム8.0gを加え、室温で30分間反応さ
せた。反応液を氷水中に注ぎ、塩酸で酸性としたのち、
ジエチルエーテルで抽出し、5%水酸化ナトリウム水溶
液および水で洗ったのち、無水硫酸マグネシウムで乾燥
した。減圧下に溶媒を留去したのち、残留物をシリカゲ
ルフラッシュカラムクロマトグラフィー(溶出溶媒:ベ
ンゼン/ヘキサン=3/1)で精製し、融点61〜65℃の2,
2,7−トリメチル−3(2H)−ベンゾフラノン2.1gを得
た。IR (neat): ν CO 1710cm -1 NMR (CDCl 3 ) δ: 1.62 (6H, s), 2.25 (3H, s), 6.82 (1H, d, J = 7.7H)
z), 6.94 (1H, t, J = 7.7Hz), 7.10 (1H, t, J = 7.7Hz), 7.
17 (1H, d, J = 7.7Hz) 2-Methyl-2- (2-methylphenoxy) propionic acid
To 11.5 g, add 80 ml of dry benzene and 4.3 ml of thionyl chloride,
The mixture was heated under reflux for 2 hours. The reaction solution was concentrated to dryness under reduced pressure,
After 80 ml of dry benzene was added to the residue, 8.0 g of anhydrous aluminum chloride was added with stirring under ice cooling, and the mixture was reacted at room temperature for 30 minutes. After pouring the reaction solution into ice water and acidifying with hydrochloric acid,
The mixture was extracted with diethyl ether, washed with 5% aqueous sodium hydroxide solution and water, and dried over anhydrous magnesium sulfate. After evaporating the solvent under reduced pressure, the residue was purified by silica gel flash column chromatography (eluting solvent: benzene / hexane = 3/1), and the melting point was 61 to 65 ° C.
2.1 g of 2,7-trimethyl-3 (2H) -benzofuranone was obtained.
元素分析値:(C11H12O2として) C% H% 計算値 74.98 6.86 実測値 74.70 6.89 IR(KBr):νCO 1715cm-1 NMR(CDCl3) δ:1.47(6H,s),2.31(3H,s),6.97(1H,t,J=7.7H
z),7.42(1H,d,J=7.7Hz),7.50(1H,d,J=7.7Hz) 2,2,7−トリメチル−3(2H)−ベンゾフラノン2.00gを
濃硫酸20mlと水40mlの混液に懸濁させ、二酸化マンガン
3.00gを加えたのち、70℃で20時間撹拌した。冷後反応
液に酢酸エチルを加え、不溶物をろ去後有機層を水洗
し、無水硫酸マグネシウムで乾燥した。減圧下に溶媒を
留去したのち、残留物をシリカゲルフラッシュカラムク
ロマトグラフィー(溶出溶媒:ベンゼン/酢酸エチル=
50/1)で精製し、融点123〜126℃の7−ホルミル−2,2
−ジメチル−3(2H)−ベンゾフラノン0.44gを得た。Elemental analysis value: (as C 11 H 12 O 2 ) C% H% Calculated value 74.98 6.86 Measured value 74.70 6.89 IR (KBr): ν CO 1715 cm −1 NMR (CDCl 3 ) δ: 1.47 (6H, s), 2.31 (3H, s), 6.97 (1H, t, J = 7.7H
z), 7.42 (1H, d, J = 7.7Hz), 7.50 (1H, d, J = 7.7Hz) 2,2,7-trimethyl-3 (2H) -benzofuranone 2.00g of concentrated sulfuric acid 20ml and water 40ml Suspend in mixed solution, manganese dioxide
After adding 3.00 g, the mixture was stirred at 70 ° C. for 20 hours. After cooling, ethyl acetate was added to the reaction solution, the insoluble material was filtered off, the organic layer was washed with water, and dried over anhydrous magnesium sulfate. After the solvent was distilled off under reduced pressure, the residue was subjected to silica gel flash column chromatography (eluting solvent: benzene / ethyl acetate =
50/1) and 7-formyl-2,2 with a melting point of 123-126 ° C.
0.44 g of -dimethyl-3 (2H) -benzofuranone was obtained.
元素分析値:(C11H10O3として) C% H% 計算値 69.46 5.30 実測値 69.53 5.29 IR(KBr):νCO 1725,1680cm-1 NMR(CDCl3) δ:1.55(6H,s),7.21(1H,t,J=7.7Hz),7.92(1H,dd,
J=1.6and7.7Hz),8.13(1H,dd,J=1.6and7.7Hz),10.3
7(1H,s) 7−ホルミル−2,2−ジメチル−3(2H)−ベンゾフラ
ノン0.40gをピリジン5mlに溶かし、マロン酸0.44gとア
ニリン0.02mlを加え、50℃で16時間撹拌後1時間加熱還
流させた。反応液を減圧下に濃縮し、塩酸で酸性とした
のち、クロロホルムで抽出し、水洗後無水硫酸マグネシ
ウムで乾燥した。減圧下に溶媒を留去後、残留物をエタ
ノール−ジエチルエーテルより再結晶し、融点206〜209
℃の3-(2,3−ジヒドロ−2,2−ジメチル−3−オキソ−
7−ベンゾフラニル)アクリル酸0.45gを得た。Elemental analysis value: (as C 11 H 10 O 3 ) C% H% Calculated value 69.46 5.30 Measured value 69.53 5.29 IR (KBr): ν CO 1725,1680 cm −1 NMR (CDCl 3 ) δ: 1.55 (6H, s) , 7.21 (1H, t, J = 7.7Hz), 7.92 (1H, dd,
J = 1.6and7.7Hz), 8.13 (1H, dd, J = 1.6and7.7Hz), 10.3
7 (1H, s) 7-formyl-2,2-dimethyl-3 (2H) -benzofuranone 0.40 g is dissolved in 5 ml of pyridine, 0.44 g of malonic acid and 0.02 ml of aniline are added, and the mixture is stirred for 16 hours at 50 ° C for 1 hour. Heated to reflux. The reaction mixture was concentrated under reduced pressure, acidified with hydrochloric acid, extracted with chloroform, washed with water, and dried over anhydrous magnesium sulfate. After evaporating the solvent under reduced pressure, the residue was recrystallized from ethanol-diethyl ether to give a melting point of 206-209.
3- (2,3-dihydro-2,2-dimethyl-3-oxo-
0.45 g of 7-benzofuranyl) acrylic acid was obtained.
元素分析値:(C13H12O4として) C% H% 計算値 67.23 5.21 実測値 67.16 5.12 IR(KBr):νCO 1715,1675cm-1 NMR(CDCl3) δ:1.54(6H,s),6.87(1H,d,J=15.9Hz),7.13(1H,t,
J=7.7Hz),7.72(1H,d,J=7.7Hz),7.74(1H,d,J=7.7
Hz),7.85(1H,d,J=15.9Hz) 参考例5 比重1.42の濃硝酸33mlと濃硫酸26mlの混液に氷冷撹拌下
に、2,2,5−トリメチル−3(2H)−ベンゾフラノン22.
5gを少量ずつ加えたのち、60℃で1時間撹拌した。反応
液を氷水中に注ぎ、ジエチルエーテルで抽出したのち、
炭酸水素ナトリウム水溶液および水で洗い、無水硫酸マ
グネシウムで乾燥した。減圧下に溶媒を留去後、残留物
をジエチルエーテル−ヘキサンより再結晶し、融点129
〜132℃の2,2,5−トリメチル−7−ニトロ−3(2H)−
ベンゾフラノン9.5gを得た。Elemental analysis value: (as C 13 H 12 O 4 ) C% H% Calculated value 67.23 5.21 Actual value 67.16 5.12 IR (KBr): ν CO 1715,1675cm −1 NMR (CDCl 3 ) δ: 1.54 (6H, s) , 6.87 (1H, d, J = 15.9Hz), 7.13 (1H, t,
J = 7.7Hz), 7.72 (1H, d, J = 7.7Hz), 7.74 (1H, d, J = 7.7
Hz), 7.85 (1H, d, J = 15.9Hz) Reference Example 5 2,3,5-Trimethyl-3 (2H) -benzofuranone was added to a mixture of 33 ml of concentrated nitric acid with a specific gravity of 1.42 and 26 ml of concentrated sulfuric acid under ice-cooling stirring. twenty two.
After adding 5g little by little, it stirred at 60 degreeC for 1 hour. The reaction solution was poured into ice water and extracted with diethyl ether,
It was washed with an aqueous sodium hydrogen carbonate solution and water, and dried over anhydrous magnesium sulfate. After evaporating the solvent under reduced pressure, the residue was recrystallized from diethyl ether-hexane to give the melting point 129.
2,2,5-Trimethyl-7-nitro-3 (2H)-
9.5 g of benzofuranone was obtained.
元素分析値:(C11H11NO4として) C% H% N% 計算値 59.73 5.01 6.33 実測値 59.44 5.00 6.56 IR(KBr):νCO 1715cm-1 νNO2 1535cm-1 NMR(CDCl3) δ:1.56(6H,s),2.46(3H,s),7.78(1H,d,J=1.1H
z),8.26(1H,d,J=1.1Hz) 2,2,5−トリメチル−7−ニトロ−3(2H)−ベンゾフ
ラノン9.0gをエタノール150mlに溶かし、1規定塩酸42m
lおよび5%パラジウム炭素0.9gを加え、室温で常圧下
に水添した。触媒をろ去し、減圧下に溶媒を留去したの
ち、残留物をジエチルエーテルで洗い、融点119〜122℃
の7−アミノ−2,2,5−トリメチル−3(2H)−ベンゾ
フラノン塩酸塩8.1gを得た。Elemental analysis value: (as C 11 H 11 NO 4 ) C% H% N% Calculated value 59.73 5.01 6.33 Measured value 59.44 5.00 6.56 IR (KBr): ν CO 1715cm −1 νNO 2 1535cm −1 NMR (CDCl 3 ) δ : 1.56 (6H, s), 2.46 (3H, s), 7.78 (1H, d, J = 1.1H
z), 8.26 (1H, d, J = 1.1Hz) 2,2,5-Trimethyl-7-nitro-3 (2H) -benzofuranone 9.0g was dissolved in 150ml ethanol and 1N hydrochloric acid 42m
l and 0.9% of 5% palladium-carbon were added and hydrogenated at room temperature under normal pressure. The catalyst was filtered off, the solvent was distilled off under reduced pressure, the residue was washed with diethyl ether, and the melting point was 119 to 122 ° C.
There was obtained 8.1 g of 7-amino-2,2,5-trimethyl-3 (2H) -benzofuranone hydrochloride.
元素分析値:(C11H14ClNO2として) C% H% N% 計算値 58.03 6.20 6.15 実測値 57.86 6.26 6.23 IR(KBr):νCO 1725cm-1 NMR(DMSO-d6) δ:1.40(6H,s),2.26(3H,s),6.1(3H,br),6.96(1
H,s),7.14(1H,s) 7−アミノ−2,2,5−トリメチル−3(2H)−ベンゾフ
ラノン塩酸塩5.0gを10%ホウフッ化水素酸水溶液20mlに
加え、氷冷撹拌下に亜硝酸ナトリウム1.7gの水9ml溶液
を滴下したのち、40分間反応させた。析出した結晶をろ
取後、5%ホウフッ化水素酸水溶液、冷メタノールおよ
び冷エタノールで順次洗い、融点230〜232℃の(2,3−
ジヒドロ−2,2,5−トリメチル−3−オキソ−7−ベン
ゾフラン)ジアゾニウム テトラフルオロボラート5.0g
を得た。Elemental analysis value: (as C 11 H 14 ClNO 2 ) C% H% N% Calculated value 58.03 6.20 6.15 Measured value 57.86 6.26 6.23 IR (KBr): ν CO 1725cm −1 NMR (DMSO-d 6 ) δ: 1.40 ( 6H, s), 2.26 (3H, s), 6.1 (3H, br), 6.96 (1
H, s), 7.14 (1H, s) 7-amino-2,2,5-trimethyl-3 (2H) -benzofuranone hydrochloride 5.0 g was added to 20 ml of a 10% aqueous solution of borofluoric acid, and the mixture was stirred under ice cooling. A solution of 1.7 g of sodium nitrite in 9 ml of water was added dropwise, and the mixture was reacted for 40 minutes. The precipitated crystals were collected by filtration, washed successively with a 5% aqueous solution of borofluoric acid, cold methanol and cold ethanol, and the melting point of 230-232 ° C (2,3-
Dihydro-2,2,5-trimethyl-3-oxo-7-benzofuran) diazonium tetrafluoroborate 5.0 g
Got
元素分析値:(C11H11BF4N2O2として) C% H% N% 計算値 45.56 3.82 9.66 実測値 45.62 3.81 9.51 IR(KBr):νN2 + 2255cm-1 νCO 1730cm-1 NMR(DMSO-d6) δ:1.58(6H,s),2.48(3H,s),8.46(1H,d,J=2.2H
z),8.66(1H,d,J=2.2Hz) (2,3−ジヒドロ−2,2,5−トリメチル−3−オキソ−7
−ベンゾフラン)ジアゾニウム テトラフルオロボラー
ト4.9gを酢酸250mlに溶かし、1時間加熱還流させた。
反応液を減圧下に濃縮したのち、水を加えジエチルエー
テルで抽出し、炭酸水素ナトリウム水溶液および水で洗
い、無水硫酸マグネシウムで乾燥した。減圧下に溶媒を
留去後、残留物をエタノール120mlに溶かし、1規定水
酸化ナトリウム水溶液28mlを加えたのち、室温で3時間
撹拌した。反応液を減圧下に濃縮後、水を加えジエチル
エーテルで洗ったのち、水層を活性炭素で処理し、塩酸
で酸性としたのち、ジエチルエーテルで抽出し、炭酸水
素ナトリウム水溶液および水で洗い、無水硫酸マグネシ
ウムで乾燥した。減圧下に溶媒を留去後、残留物をジエ
チルエーテル−ヘキサンより再結晶し、融点165〜168℃
の7−ヒドロキシ−2,2,5−トリメチル−3(2H)−ベ
ンゾフラノン1.8gを得た。Elemental analysis value: (as C 11 H 11 BF 4 N 2 O 2 ) C% H% N% Calculated value 45.56 3.82 9.66 Measured value 45.62 3.81 9.51 IR (KBr): ν N 2 + 2255cm -1 ν CO 1730cm -1 NMR (DMSO-d 6 ) δ: 1.58 (6H, s), 2.48 (3H, s), 8.46 (1H, d, J = 2.2H
z), 8.66 (1H, d, J = 2.2Hz) (2,3-dihydro-2,2,5-trimethyl-3-oxo-7
-Benzofuran) diazonium Tetrafluoroborate (4.9 g) was dissolved in acetic acid (250 ml) and heated under reflux for 1 hour.
The reaction mixture was concentrated under reduced pressure, water was added, the mixture was extracted with diethyl ether, washed with aqueous sodium hydrogen carbonate solution and water, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, the residue was dissolved in 120 ml of ethanol, 28 ml of a 1N aqueous sodium hydroxide solution was added, and the mixture was stirred at room temperature for 3 hours. The reaction mixture was concentrated under reduced pressure, water was added, and the mixture was washed with diethyl ether, the aqueous layer was treated with activated carbon, acidified with hydrochloric acid, extracted with diethyl ether, washed with aqueous sodium hydrogen carbonate solution and water, It was dried over anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure, the residue was recrystallized from diethyl ether-hexane, and the melting point was 165 to 168 ° C.
1.8 g of 7-hydroxy-2,2,5-trimethyl-3 (2H) -benzofuranone were obtained.
元素分析値:(C11H12O3として) C% H% 計算値 68.74 6.29 実測値 68.50 6.28 IR(KBr):νOH 3175cm-1 νCO 1675cm-1 NMR(CDCl3) δ:1.47(6H,s),2.31(3H,s),5.09(1H,s),7.01(1
H,s),7.03(1H,s) エタノール30mlに氷冷撹拌下に60%水素化ナトリウム
(油性)0.48gを少量ずつ加えたのち、7−ヒドロキシ
−2,2,5−トリメチル−3(2H)−ベンゾフラノン1.22g
とヨウ化メチル0.9mlを加え、14時間加熱還流させた。
反応液を減圧下に濃縮後、水を加えジエチルエーテルで
抽出し、水洗後無水硫酸マグネシウムで乾燥した。減圧
下に溶媒を留去後、残留物をシリカゲルフラッシュカラ
ムクロマトグラフィー(溶出溶媒:ベンゼン)で精製
し、融点46〜49℃の7−メトキシ−2,2,5−トリメチル
−3(2H)−ベンゾフラノン1.17gを得た。Elemental analysis value: (as C 11 H 12 O 3 ) C% H% Calculated value 68.74 6.29 Measured value 68.50 6.28 IR (KBr): ν OH 3175cm -1 ν CO 1675cm -1 NMR (CDCl 3 ) δ: 1.47 (6H , s), 2.31 (3H, s), 5.09 (1H, s), 7.01 (1
H, s), 7.03 (1H, s) To 30 ml of ethanol, 0.48 g of 60% sodium hydride (oil) was added little by little under ice-cooling stirring, and then 7-hydroxy-2,2,5-trimethyl-3 ( 2H) -Benzofuranone 1.22 g
And 0.9 ml of methyl iodide were added, and the mixture was heated under reflux for 14 hours.
The reaction mixture was concentrated under reduced pressure, water was added, the mixture was extracted with diethyl ether, washed with water, and dried over anhydrous magnesium sulfate. After evaporating the solvent under reduced pressure, the residue was purified by silica gel flash column chromatography (eluting solvent: benzene), and 7-methoxy-2,2,5-trimethyl-3 (2H)-having a melting point of 46 to 49 ° C. 1.17 g of benzofuranone was obtained.
元素分析値:(C12H14O3として) C% H% 計算値 69.89 6.84 実測値 69.98 6.89 IR(KBr):νCO 1705cm-1 NMR(CDCl3) δ:1.49(6H,s),2.36(3H,s),3.94(3H,s),6.94(1
H,s),7.04(1H,s) 7−メトキシ−2,2,5−トリメチル−3(2H)−ベンゾ
フラノン0.60gをアセトニトリル36mlに溶かし、過硫酸
カリウム1.57gの水24ml溶液および無水硫酸銅90mgを室
温で撹拌下に加えたのち、70℃で13時間反応させた。反
応液を減圧下に濃縮後、水を加えジエチルエーテルで抽
出し、炭酸水素ナトリウム水溶液および水で洗ったの
ち、無水硫酸マグネシウムで乾燥した。減圧下に溶媒を
留去し、残留物をジエチルエーテル−ヘキサンより再結
晶し、融点123〜126℃の5−ホルミル−7−メトキシ−
2,2−ジメチル−3(2H)−ベゾフラノン0.49gを得た。Elemental analysis value: (as C 12 H 14 O 3 ) C% H% Calculated value 69.89 6.84 Measured value 69.98 6.89 IR (KBr): ν CO 1705 cm −1 NMR (CDCl 3 ) δ: 1.49 (6H, s), 2.36 (3H, s), 3.94 (3H, s), 6.94 (1
H, s), 7.04 (1H, s) 7-methoxy-2,2,5-trimethyl-3 (2H) -benzofuranone (0.60 g) was dissolved in 36 ml of acetonitrile, and 1.57 g of potassium persulfate in 24 ml of water and anhydrous copper sulfate. After 90 mg was added at room temperature with stirring, the mixture was reacted at 70 ° C. for 13 hours. The reaction mixture was concentrated under reduced pressure, water was added, the mixture was extracted with diethyl ether, washed with aqueous sodium hydrogen carbonate solution and water, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was recrystallized from diethyl ether-hexane to give 5-formyl-7-methoxy-mp having a melting point of 123 to 126 ° C.
0.49 g of 2,2-dimethyl-3 (2H) -bezofuranone was obtained.
元素分析値:(C12H12O4として) C% H% 計算値 65.45 5.49 実測値 65.53 5.48 IR(KBr):νCO 1705,1680cm-1 NMR(CDCl3) δ:1.56(6H,s),4.03(3H,s),7.67(1H,d,J=1.7H
z),7.77(1H,d,J=1.7Hz),9.92(1H,s) 5−ホルミル−7−メトキシ−2,2−ジメチル−3(2
H)−ベンゾフラノン0.48gをピリジン15mlに溶かし、マ
ロン酸0.48gおよびピペリジン0.05mlを加え、50℃で14
時間撹拌後、2時間加熱還流させた。反応液を減圧下に
濃縮後、水を加え塩酸で酸性としたのち、クロロホルム
で抽出し、水洗後無水硫酸マグネシウムで乾燥した。減
圧下に溶媒を留去し、残留物をエタノール−ヘキサンよ
り再結晶し、融点193〜196℃の3−(2,3−ジヒドロ−
7−メトキシ−2,2−ジメチル−3−オキソ−5−ベン
ゾフラニル)アクリル酸0.30gを得た。Elemental analysis value: (as C 12 H 12 O 4 ) C% H% Calculated value 65.45 5.49 Measured value 65.53 5.48 IR (KBr): ν CO 1705,1680 cm −1 NMR (CDCl 3 ) δ: 1.56 (6H, s) , 4.03 (3H, s), 7.67 (1H, d, J = 1.7H
z), 7.77 (1H, d, J = 1.7Hz), 9.92 (1H, s) 5-formyl-7-methoxy-2,2-dimethyl-3 (2
H) -benzofuranone 0.48 g was dissolved in pyridine 15 ml, malonic acid 0.48 g and piperidine 0.05 ml were added, and the mixture was stirred at 50 ° C for 14
After stirring for an hour, the mixture was heated to reflux for 2 hours. The reaction solution was concentrated under reduced pressure, water was added, and the mixture was acidified with hydrochloric acid, extracted with chloroform, washed with water, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was recrystallized from ethanol-hexane to give 3- (2,3-dihydro-
0.30 g of 7-methoxy-2,2-dimethyl-3-oxo-5-benzofuranyl) acrylic acid was obtained.
元素分析値:(C14H14O5として) C% H% 計算値 64.12 5.38 実測値 63.83 5.64 IR(KBr):νCO 1715,1685cm-1 NMR(CDCl3) δ:1.53(6H,s),4.01(3H,s),6.38(1H,d,J=15.9H
z),7.28(1H,d,J=1.1Hz),7.45(1H,d,J=1.1Hz),7.
75(1H,d,J=15.9Hz) 参考例6 2,4−ジメトキシケイ皮酸メチル3.28gを乾燥塩化メチレ
ン70mlに溶かし、氷冷撹拌下に無水塩化アルミニウム3.
68gを加えたのち、加熱還流下に撹拌しながら、2−ブ
ロモ−2−メチルプロピオニルブロミド2.1mlを滴下
後、4時間加熱還流させた。反応液を氷水中に注ぎ、塩
酸で酸性とし、クロロホルムを加え1.5時間撹拌したの
ち、有機層を分取した。有機層を水洗し無水硫酸マグネ
シウムで乾燥後、減圧下に溶媒を留去した。残留物をシ
リカゲルフラッシュカラムクロマトグラフィー(溶出溶
媒:クロロホルム)で精製し、油状の5-(2−ブロモ−
2−メチルプロピオニル)−4−ヒドロキシ−2−メト
キシケイ皮酸メチル2.19gを得た。Elemental analysis value: (as C 14 H 14 O 5 ) C% H% Calculated value 64.12 5.38 Measured value 63.83 5.64 IR (KBr): ν CO 1715,1685 cm −1 NMR (CDCl 3 ) δ: 1.53 (6H, s) , 4.01 (3H, s), 6.38 (1H, d, J = 15.9H
z), 7.28 (1H, d, J = 1.1Hz), 7.45 (1H, d, J = 1.1Hz), 7.
75 (1H, d, J = 15.9Hz) Reference Example 6 3.28 g of methyl 2,4-dimethoxycinnamate was dissolved in 70 ml of dry methylene chloride, and anhydrous aluminum chloride under ice-cooling stirring 3.
After 68 g was added, 2.1 ml of 2-bromo-2-methylpropionyl bromide was added dropwise with stirring with heating under reflux, and the mixture was heated under reflux for 4 hours. The reaction solution was poured into ice water, acidified with hydrochloric acid, chloroform was added and the mixture was stirred for 1.5 hours, then, the organic layer was separated. The organic layer was washed with water, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel flash column chromatography (eluting solvent: chloroform) to give oily 5- (2-bromo-).
2.19 g of methyl 2-methylpropionyl) -4-hydroxy-2-methoxycinnamate was obtained.
IR(neat):νCO 1710,1620cm-1 NMR(CDCl3) δ:2.08(6H,s),3.81(3H,s),3.94(3H,s),6.47(1
H,s),6.48(1H,d,J=15.9Hz),7.84(1H,d,J=15.9H
z),8.70(1H,s),12.70(1H,s) 5-(2−ブロモ−2−メチルプロピオニル)−4−ヒド
ロキシ−2−メトキシケイ皮酸メチル2.18gを乾燥1,2−
ジメトキシエタン40mlに溶かし、無水炭酸カリウム2.20
gとヨウ化ナトリウム1.38gを加え、80℃で2時間撹拌し
た。反応液を減圧下に濃縮後、水を加えクロロホルムで
抽出し、水洗後無水硫酸マグネシウムで乾燥した。減圧
下に溶媒を留去後、残留物をクロロホルム−ヘキサンよ
り再結晶し、融点169〜171℃の3-(2,3−ジヒドロ−6
−メトキシ−2,2−ジメチル−3−オキソ−5−ベンゾ
フラニル)アクリル酸メチル1.29gを得た。IR (neat): ν CO 1710,1620cm -1 NMR (CDCl 3 ) δ: 2.08 (6H, s), 3.81 (3H, s), 3.94 (3H, s), 6.47 (1
H, s), 6.48 (1H, d, J = 15.9Hz), 7.84 (1H, d, J = 15.9H)
z), 8.70 (1H, s), 12.70 (1H, s) Methyl 5- (2-bromo-2-methylpropionyl) -4-hydroxy-2-methoxycinnamate 2.18 g was dried 1,2-
Dissolve in 40 ml of dimethoxyethane, anhydrous potassium carbonate 2.20
g and 1.38 g of sodium iodide were added, and the mixture was stirred at 80 ° C. for 2 hours. The reaction mixture was concentrated under reduced pressure, water was added, the mixture was extracted with chloroform, washed with water, and dried over anhydrous magnesium sulfate. After evaporating the solvent under reduced pressure, the residue was recrystallized from chloroform-hexane to give 3- (2,3-dihydro-6) having a melting point of 169 to 171 ° C.
There were obtained 1.29 g of methyl -methoxy-2,2-dimethyl-3-oxo-5-benzofuranyl) acrylate.
元素分析値:(C15H16O5として) C% H% 計算値 65.21 5.84 実測値 64.89 5.77 IR(KBr):νCO 1715,1700cm-1 NMR(CDCl3) δ:1.47(6H,s),3.80(3H,s),3.97(3H,s),6.45(1
H,d,J=15.9Hz),6.52(1H,s),7.84(1H,s),7.92(1
H,d,J=15.9Hz) 3-(2,3−ジヒドロ−6−メトキシ−2,2−ジメチル−3
−オキソ−5−ベンゾフラニル)アクリル酸メチル1.28
gをエタノール30mlに溶かし、2規定水酸化ナトリウム
水溶液4.7mlを加え、50℃で1.5時間撹拌した。反応液を
減圧下に濃縮後残留物を水に溶かし、塩化メチレンで抽
出した。水層を活性炭素で処理し、塩酸で酸性としたの
ち、塩化メチレンで抽出し、水洗後無水硫酸マグネシウ
ムで乾燥した。減圧下に溶媒を留去し、残留物をジエチ
ルエーテル−ヘキサンより再結晶し、融点225〜228℃の
3-(2,3−ジヒドロ−6−メトキシ−2,2−ジメチル−3
−オキソ−5−ベンゾフラニル)アクリル酸0.81gを得
た。Elemental analysis value: (as C 15 H 16 O 5 ) C% H% Calculated value 65.21 5.84 Actual value 64.89 5.77 IR (KBr): ν CO 1715,1700cm −1 NMR (CDCl 3 ) δ: 1.47 (6H, s) , 3.80 (3H, s), 3.97 (3H, s), 6.45 (1
H, d, J = 15.9Hz), 6.52 (1H, s), 7.84 (1H, s), 7.92 (1
H, d, J = 15.9Hz) 3- (2,3-dihydro-6-methoxy-2,2-dimethyl-3
-Oxo-5-benzofuranyl) methyl acrylate 1.28
g was dissolved in 30 ml of ethanol, 4.7 ml of 2N aqueous sodium hydroxide solution was added, and the mixture was stirred at 50 ° C. for 1.5 hours. The reaction mixture was concentrated under reduced pressure, the residue was dissolved in water, and the mixture was extracted with methylene chloride. The aqueous layer was treated with activated carbon, acidified with hydrochloric acid, extracted with methylene chloride, washed with water, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, the residue was recrystallized from diethyl ether-hexane, and the melting point was 225 to 228 ° C.
3- (2,3-dihydro-6-methoxy-2,2-dimethyl-3
0.81 g of -oxo-5-benzofuranyl) acrylic acid was obtained.
元素分析値:(C14H14O5として) C% H% 計算値 64.12 5.38 実測値 63.83 5.41 IR(KBr):νCO 1705,1685cm-1 NMR(DMSO-d6) δ:1.40(6H,s),3.99(3H,s),6.52(1H,d,J=15.9H
z),6.89(1H,s),7.75(1H,d,J=15.9Hz),7.94(1H,
s),12.24(1H,br-s) 参考例7 2,4−ジメトキシケイ皮酸5.21gに乾燥ベンゼン100mlと
塩化チオニル9mlを加え、2時間加熱還流後、反応液を
減圧下に濃縮乾固した。この残留物の乾燥塩化メチレン
70ml溶液をピペリジン3.8mlとトリエチルアミン7.0mlの
乾燥塩化メチレン30ml溶液に氷冷撹拌下に滴下したの
ち、室温で17時間反応させた。反応液を希塩酸、水、炭
酸水素ナトリウム水溶液および水で順次洗ったのち、無
水硫酸マグネシウムで乾燥後減圧下に溶媒を留去した。
残留物をクロロホルム−ヘキサンより再結晶し、融点11
1〜112℃の1-(2,4−ジメトキシシンナモイル)ピペリ
ジン4.83gを得た。Elemental analysis value: (as C 14 H 14 O 5 ) C% H% Calculated value 64.12 5.38 Measured value 63.83 5.41 IR (KBr): ν CO 1705,1685 cm −1 NMR (DMSO-d 6 ) δ: 1.40 (6H, s), 3.99 (3H, s), 6.52 (1H, d, J = 15.9H
z), 6.89 (1H, s), 7.75 (1H, d, J = 15.9Hz), 7.94 (1H,
s), 12.24 (1H, br-s) Reference Example 7 To 5.21 g of 2,4-dimethoxycinnamic acid was added 100 ml of dry benzene and 9 ml of thionyl chloride, and the mixture was heated under reflux for 2 hours, and the reaction solution was concentrated to dryness under reduced pressure. did. Dry methylene chloride of this residue
The 70 ml solution was added dropwise to a solution of 3.8 ml of piperidine and 7.0 ml of triethylamine in 30 ml of dry methylene chloride under ice cooling with stirring, and then the mixture was reacted at room temperature for 17 hours. The reaction solution was washed successively with diluted hydrochloric acid, water, aqueous sodium hydrogen carbonate solution and water, dried over anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure.
The residue was recrystallized from chloroform-hexane, melting point 11
There were obtained 4.83 g of 1- (2,4-dimethoxycinnamoyl) piperidine at 1-112 ° C.
元素分析値:(C16H21NO3として) C% H% N% 計算値 69.79 7.69 5.09 実測値 69.53 7.77 4.99 IR(KBr):νCO 1635cm-1 NMR(CDCl3) δ:1.55〜1.75(6H,m),3.55〜3.7(4H,m),3.83(3H,
s),3.86(3H,s),6.45〜6.55(2H,m),6.91(1H,d,J=
15.4Hz),7.42(1H,d,J=8.8Hz),7.83(1H,d,J=15.4H
z) 1-(2,4−ジメトキシシンナモイル)ピペリジン1.76gを
乾燥塩化メチレン20mlに溶かし、氷冷撹拌下に無水塩化
アルミニウム1.88gを加えたのち、加熱還流下に撹拌し
ながら、2−ブロモ−2−メチルプロピオニルブロミド
1.1mlを滴下後、4時間加熱還流させた。反応液を氷水
中に注ぎ、塩酸で酸性とし、クロロホルムを加え1時間
撹拌したのち、有機層を分取し、水洗後無水硫酸マグネ
シウムで乾燥した。減圧下に溶媒を留去後、残留物をシ
リカゲルフラッシュカラムクロマトグラフィー(溶出溶
媒:クロロホルム/ベンゼン=50/1)で精製し、油状の
1-〔5-(2−ブロモ−2−メチルプロピオニル)−4−
ヒドロキシ−2−メトキシシンナモイル〕ピペリジン1.
49gを得た。Elemental analysis value: (as C 16 H 21 NO 3 ) C% H% N% Calculated value 69.79 7.69 5.09 Measured value 69.53 7.77 4.99 IR (KBr): ν CO 1635cm −1 NMR (CDCl 3 ) δ: 1.55 to 1.75 ( 6H, m), 3.55 to 3.7 (4H, m), 3.83 (3H,
s), 3.86 (3H, s), 6.45 to 6.55 (2H, m), 6.91 (1H, d, J =
15.4Hz), 7.42 (1H, d, J = 8.8Hz), 7.83 (1H, d, J = 15.4H)
z) 1.76 g of 1- (2,4-dimethoxycinnamoyl) piperidine is dissolved in 20 ml of dry methylene chloride, 1.88 g of anhydrous aluminum chloride is added under ice-cooling stirring, and then 2-bromo is added while stirring under heating under reflux. -2-Methylpropionyl bromide
After dropwise adding 1.1 ml, the mixture was refluxed for 4 hours. The reaction solution was poured into ice water, acidified with hydrochloric acid, chloroform was added and the mixture was stirred for 1 hour. Then, the organic layer was separated, washed with water and dried over anhydrous magnesium sulfate. After evaporating the solvent under reduced pressure, the residue was purified by silica gel flash column chromatography (eluting solvent: chloroform / benzene = 50/1) to give an oil.
1- [5- (2-bromo-2-methylpropionyl) -4-
Hydroxy-2-methoxycinnamoyl] piperidine 1.
Got 49g.
IR(neat):νco 1635cm-1 NMR(CDCl3) δ:1.55〜1.75(6H,m),2.08(6H,s),3.5〜3.75(4H,
m),3.93(3H,s),6.46(1H,s),6.98(1H,d,J=15.9H
z),7.72(1H,d,J=15.9Hz),8.64(1H,s),12.64(1H,
s) 参考例8 2,2,5−トリメチル−3(2H)−ベンゾフラノン7.40gの
酢酸10ml溶液に、70℃で撹拌下に臭素2.3mlの酢酸2ml溶
液を滴下したのち、1時間反応させた。反応液を減圧下
に濃縮後、炭酸水素ナトリウム水溶液を加えジエチルエ
ーテルで抽出し、水洗後無水硫酸マグネシウムで乾燥し
た。減圧下に溶媒を留去後、残留物をヘキサンより再結
晶し、融点140〜144℃の7−ブロモ−2,2,5−トリメチ
ル−3(2H)−ベンゾフラノン5.53gを得た。IR (neat): νco 1635 cm -1 NMR (CDCl 3 ) δ: 1.55 to 1.75 (6H, m), 2.08 (6H, s), 3.5 to 3.75 (4H,
m), 3.93 (3H, s), 6.46 (1H, s), 6.98 (1H, d, J = 15.9H
z), 7.72 (1H, d, J = 15.9Hz), 8.64 (1H, s), 12.64 (1H,
s) Reference Example 8 To a solution of 7.40 g of 2,2,5-trimethyl-3 (2H) -benzofuranone in 10 ml of acetic acid was added dropwise a solution of 2.3 ml of bromine in 2 ml of acetic acid with stirring at 70 ° C., and then reacted for 1 hour. . The reaction mixture was concentrated under reduced pressure, an aqueous sodium hydrogen carbonate solution was added, the mixture was extracted with diethyl ether, washed with water, and dried over anhydrous magnesium sulfate. After evaporating the solvent under reduced pressure, the residue was recrystallized from hexane to obtain 5.53 g of 7-bromo-2,2,5-trimethyl-3 (2H) -benzofuranone having a melting point of 140 to 144 ° C.
元素分析値:(C11H11BrO2として) C% H% 計算値 51.79 4.35 実測値 52.05 4.43 IR(KBr):νCO 1705cm-1 NMR(CDCl3) δ:1.50(6H,s),2.35(3H,s),7.40(1H,d,J=1.7H
z),7.64(1H,d,J=1.7Hz) 参考例9 過硫酸カリウム5.85gと硫酸銅5水和物0.51gを水60mlに
加え、室温で撹拌下に7−ブロモ−2,2,5−トリメチル
−3(2H)−ベンゾフラノン1.50gのアセトニトリル60m
l溶液を加えたのち、70℃で10時間撹拌し、反応液を減
圧下に濃縮した。残留物に水を加え酢酸エチルで抽出
し、水洗後炭酸水素ナトリウム水溶液を加えよく振り混
ぜた。水層を分取し、塩酸で酸性としたのち、酢酸エチ
ルで抽出し、水洗後無水硫酸マグネシウムで乾燥した。
減圧下に溶媒を留去後、残留物を含水エタノールより再
結晶し、融点251〜253℃の7−ブロモ−2,3−ジヒドロ
−2,2−ジメチル−3−オキソ−5−ベンゾフランカル
ボン酸0.96gを得た。Elemental analysis value: (as C 11 H 11 BrO 2 ) C% H% Calculated value 51.79 4.35 Measured value 52.05 4.43 IR (KBr): ν CO 1705cm −1 NMR (CDCl 3 ) δ: 1.50 (6H, s), 2.35 (3H, s), 7.40 (1H, d, J = 1.7H
z), 7.64 (1H, d, J = 1.7 Hz) Reference Example 9 5.85 g of potassium persulfate and 0.51 g of copper sulfate pentahydrate were added to 60 ml of water, and 7-bromo-2,2,2, 5-Trimethyl-3 (2H) -benzofuranone 1.50 g of acetonitrile 60 m
After the solution was added, the mixture was stirred at 70 ° C. for 10 hours, and the reaction solution was concentrated under reduced pressure. Water was added to the residue and the mixture was extracted with ethyl acetate. After washing with water, an aqueous sodium hydrogen carbonate solution was added and the mixture was shaken well. The aqueous layer was separated, acidified with hydrochloric acid, extracted with ethyl acetate, washed with water, and dried over anhydrous magnesium sulfate.
After distilling off the solvent under reduced pressure, the residue was recrystallized from water-containing ethanol to give 7-bromo-2,3-dihydro-2,2-dimethyl-3-oxo-5-benzofurancarboxylic acid having a melting point of 251 to 253 ° C. Obtained 0.96 g.
元素分析値:(C11H9BrO4として) C% H% 計算値 46.34 3.18 実測値 46.15 3.15 IR(KBr):νCO 1725,1690cm-1 NMR(DMSO-d6) δ:1.49(6H,s),8.10(1H,d,J=1.7Hz),8.42(1H,d,J
=1.7Hz),13.41(1H,br-s) 7−ブロモ−2,3−ジヒドロ−2,2−ジメチル−3−オキ
ソ−5−ベンゾフランカルボン酸0.77gに乾燥ベンゼン2
0mlと塩化チオニル1mlを加え、2時間加熱還流させた。
反応液を減圧下に濃縮後残留物に無水エタノール20mlを
加え1時間加熱還流させた。反応液を減圧下の濃縮し、
残留物に炭酸水素ナトリウム水溶液を加えたのち、ジエ
チルエーテルで抽出し、水洗後無水硫酸アグネシウムで
乾燥した。減圧下に溶媒を留去後、残留物をジエチルエ
ーテル−ヘキサンより再結晶し、融点134〜136℃の7−
ブロモ−2,3−ジヒドロ−2,2−ジメチル−3−オキソ−
5−ベンゾフランカルボン酸エチル0.71gを得た。Elemental analysis value: (as C 11 H 9 BrO 4 ) C% H% Calculated value 46.34 3.18 Measured value 46.15 3.15 IR (KBr): ν CO 1725,1690 cm −1 NMR (DMSO-d 6 ) δ: 1.49 (6H, s), 8.10 (1H, d, J = 1.7Hz), 8.42 (1H, d, J
= 1.7Hz), 13.41 (1H, br-s) 7-Bromo-2,3-dihydro-2,2-dimethyl-3-oxo-5-benzofurancarboxylic acid 0.77g to dry benzene 2
0 ml and 1 ml of thionyl chloride were added, and the mixture was heated under reflux for 2 hours.
The reaction solution was concentrated under reduced pressure, 20 ml of absolute ethanol was added to the residue, and the mixture was heated under reflux for 1 hour. The reaction solution is concentrated under reduced pressure,
An aqueous solution of sodium hydrogen carbonate was added to the residue, which was then extracted with diethyl ether, washed with water, and dried over anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure, the residue was recrystallized from diethyl ether-hexane to give 7-mp of melting point 134-136 ° C.
Bromo-2,3-dihydro-2,2-dimethyl-3-oxo-
0.71 g of ethyl 5-benzofurancarboxylate was obtained.
元素分析値:(C13H13BrO4として) C% H% 計算値 49.86 4.18 実測値 50.00 4.21 IR(KBr):νCO 1735,1710cm-1 NMR(CDCl3) δ:1.40(3H,t,J=7.1Hz),1.55(6H,s),4.39(2H,q,J
=7.1Hz),8.32(1H,d,J=1.6Hz),8.51(1H,d,J=1.6H
z) 参考例10 5−ホルミル−2,2−ジメチル−3(2H)−ベンゾフラ
ノン6.05gを比重1.52の発煙硝酸6.7mlと無水酢酸11mlの
混液中に、ドライアイス−アセトンで冷却し撹拌下に内
温を−10〜20℃に保ちながら加えたのち、室温で7時間
反応させた。反応液を氷水中に注ぎ、ベンゼンで抽出
し、水、炭酸水素ナトリウム水溶液および水で順次洗
い、無水硫酸マグネシウムで乾燥後、減圧下に溶媒を留
去した。残留物をエタノール100mlに溶かし15%塩酸30m
lを加え1時間加熱還流させた。反応液を減圧下に濃縮
後、水を加えベンゼンで抽出し、水、炭酸水素ナトリウ
ム水溶液および水で順次洗い、無水硫酸マグネシウムで
乾燥した。減圧下に溶媒を留去後、残留物をベンゼン−
ヘキサンより再結晶し、融点168〜171℃の5−ホルミル
−2,2−ジメチル−7−ニトロ−3(2H)−ベンゾフラ
ノン3.77gを得た。Elemental analysis value: (as C 13 H 13 BrO 4 ) C% H% Calculated value 49.86 4.18 Found value 50.00 4.21 IR (KBr): ν CO 1735,1710 cm −1 NMR (CDCl 3 ) δ: 1.40 (3H, t, J = 7.1Hz), 1.55 (6H, s), 4.39 (2H, q, J
= 7.1Hz), 8.32 (1H, d, J = 1.6Hz), 8.51 (1H, d, J = 1.6H)
z) Reference example 10 5-formyl-2,2-dimethyl-3 (2H) -benzofuranone 6.05 g in a mixed solution of 6.7 ml of fuming nitric acid having a specific gravity of 1.52 and 11 ml of acetic anhydride was cooled with dry ice-acetone and stirred. After adding while maintaining the internal temperature at -10 to 20 ° C, the mixture was reacted at room temperature for 7 hours. The reaction solution was poured into ice water, extracted with benzene, washed successively with water, an aqueous sodium hydrogen carbonate solution and water, dried over anhydrous magnesium sulfate, and then the solvent was distilled off under reduced pressure. Dissolve the residue in 100 ml of ethanol and add 15% hydrochloric acid 30 m.
l was added and the mixture was heated to reflux for 1 hour. The reaction mixture was concentrated under reduced pressure, water was added, the mixture was extracted with benzene, washed successively with water, aqueous sodium hydrogen carbonate solution and water, and dried over anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure, the residue was treated with benzene.
Recrystallization from hexane gave 3.77 g of 5-formyl-2,2-dimethyl-7-nitro-3 (2H) -benzofuranone having a melting point of 168-171 ° C.
元素分析値:(C11H9NO5として) C% H% N% 計算値 56.17 3.86 5.96 実測値 56.17 3.71 6.00 IR(KBr):νCO 1730,1680cm-1 νNO2 1535cm-1 NMR(CDCl3) δ:1.63(6H,s),8.48(1H,d,J=1.7Hz),8.95(1H,d,J
=1.7Hz),10.05(1H,s) 実施例1 3-(2,3−ジヒドロ−2,2−ジメチル−3−オキソ−5−
ベンゾフラニル)アクリル酸0.70gに乾燥ベンゼン10ml
と塩化チオニル1.1mlを加え、2時間加熱還流させた。
反応液を減圧下に濃縮乾固し、この残留物の乾燥塩化メ
チレン20ml溶液を氷冷撹拌下にトリエチルアミン0.44ml
およびピロリジン0.38mlの乾燥塩化メチレン5ml溶液に
滴下したのち、室温で16時間撹拌した。反応液を希塩
酸、水、炭酸水素ナトリウム水溶液および水で順次洗っ
たのち、無水硫酸マグネシウムで乾燥した。減圧下に溶
媒を留去後、残留物をエタノール−ジエチルエーテルよ
り再結晶し、融点172〜175℃の1-〔3-(2,3−ジヒドロ
−2,2−ジメチル−3−オキソ−5−ベンゾフラニル)
アクリロイル〕ピロリジン0.47gを得た。Elemental analysis value: (as C 11 H 9 NO 5 ) C% H% N% Calculated value 56.17 3.86 5.96 Measured value 56.17 3.71 6.00 IR (KBr): ν CO 1730,1680cm −1 νNO 2 1535cm −1 NMR (CDCl 3 ) Δ: 1.63 (6H, s), 8.48 (1H, d, J = 1.7Hz), 8.95 (1H, d, J
= 1.7 Hz), 10.05 (1 H, s) Example 1 3- (2,3-dihydro-2,2-dimethyl-3-oxo-5-
Benzofuranyl) acrylic acid 0.70g to dry benzene 10ml
And 1.1 ml of thionyl chloride were added and the mixture was heated under reflux for 2 hours.
The reaction mixture was concentrated to dryness under reduced pressure, and a solution of this residue in 20 ml of dry methylene chloride was added to 0.44 ml of triethylamine with stirring under ice cooling.
After dropwise addition of 0.38 ml of pyrrolidine to a solution of 5 ml of dry methylene chloride, the mixture was stirred at room temperature for 16 hours. The reaction solution was washed successively with diluted hydrochloric acid, water, an aqueous sodium hydrogen carbonate solution and water, and then dried over anhydrous magnesium sulfate. After evaporating the solvent under reduced pressure, the residue was recrystallized from ethanol-diethyl ether to give 1- [3- (2,3-dihydro-2,2-dimethyl-3-oxo-5) having a melting point of 172-175 ° C. -Benzofuranyl)
Acryloyl] pyrrolidine (0.47 g) was obtained.
元素分析値:(C17H19NO3として) C% H% N% 計算値 71.56 6.71 4.91 実測値 71.64 6.83 4.86 IR(KBr):νCO 1700,1650cm-1 NMR(CDCl3) δ:1.49(6H,s),1.85〜2.1(4H,m),3.55〜3.7(4H,
m),6.69(1H,d,J=15.4Hz),7.09(1H,d,J=88Hz),7.
69(1H,d,J=15.4Hz),7.78(1H,dd,J=2.2and8.8Hz),
7.87(1H,d,J=2.2Hz) 実施例2 3-(2,3−ジヒドロ−2,2−ジメチル−3−オキソ−5−
ベンゾフラニル)アクリル酸0.84gおよびピペリジン0.5
4mlを用い、実施例1と同様に反応させ処理したのち、
含水エタノールより再結晶し、融点129〜130℃の1-〔3-
(2,3−ジヒドロ−2,2−ジメチル−3−オキソ−5−ベ
ンゾフラニル)アクリロイル〕ピペリジン1.00gを得
た。Elemental analysis value: (as C 17 H 19 NO 3 ) C% H% N% Calculated value 71.56 6.71 4.91 Measured value 71.64 6.83 4.86 IR (KBr): ν CO 1700,1650 cm −1 NMR (CDCl 3 ) δ: 1.49 ( 6H, s), 1.85 to 2.1 (4H, m), 3.55 to 3.7 (4H,
m), 6.69 (1H, d, J = 15.4Hz), 7.09 (1H, d, J = 88Hz), 7.
69 (1H, d, J = 15.4Hz), 7.78 (1H, dd, J = 2.2and8.8Hz),
7.87 (1H, d, J = 2.2Hz) Example 2 3- (2,3-dihydro-2,2-dimethyl-3-oxo-5-
Benzofuranyl) acrylic acid 0.84 g and piperidine 0.5
After using 4 ml of the same reaction and treatment as in Example 1,
Recrystallized from water-containing ethanol, 1- [3-
1.00 g of (2,3-dihydro-2,2-dimethyl-3-oxo-5-benzofuranyl) acryloyl] piperidine was obtained.
元素分析値:(C18H21NO3として) C% H% N% 計算値 72.22 7.07 4.68 実測値 72.17 7.33 4.71 IR(KBr):νCO 1705,1640cm-1 NMR(CDCl3) δ:1.49(6H,s),1.55〜1.75(6H,m),3.55〜3.75(4H,
m),6.87(1H,d,J=15.4Hz),7.08(1H,d,J=8.2Hz),
7.64(1H,d,J=15.4Hz),7.76(1H,dd,J=1.7and8.2H
z),7.85(1H,d,J=1.7Hz) 実施例3 3-(2,3−ジヒドロ−2,2−ジメチル−3−オキソ−5−
ベンゾフラニル)アクリル酸0.80gと4−メチルピペリ
ジン0.62mlを用い、実施例1と同様に反応させ処理した
のち、クロロホルム−ヘキサンより再結晶し、融点166
〜168℃の1-〔3-(2,3−ジヒドロ−2,2−ジメチル−3
−オキソ−5−ベンゾフラニル)アクリロイル〕−4−
メチルピペリジン0.92gを得た。Elemental analysis: (C 18 as H 21 NO 3) C% H % N% Calculated 72.22 7.07 4.68 Found 72.17 7.33 4.71 IR (KBr): ν CO 1705,1640cm -1 NMR (CDCl 3) δ: 1.49 ( 6H, s), 1.55 to 1.75 (6H, m), 3.55 to 3.75 (4H,
m), 6.87 (1H, d, J = 15.4Hz), 7.08 (1H, d, J = 8.2Hz),
7.64 (1H, d, J = 15.4Hz), 7.76 (1H, dd, J = 1.7and8.2H
z), 7.85 (1H, d, J = 1.7Hz) Example 3 3- (2,3-Dihydro-2,2-dimethyl-3-oxo-5-
(Benzofuranyl) acrylic acid (0.80 g) and 4-methylpiperidine (0.62 ml) were used and treated in the same manner as in Example 1, followed by recrystallization from chloroform-hexane to give a melting point of 166.
1- [3- (2,3-dihydro-2,2-dimethyl-3 at ~ 168 ° C
-Oxo-5-benzofuranyl) acryloyl] -4-
0.92 g of methylpiperidine was obtained.
元素分析値:(C19H23NO3として) C% H% N% 計算値 72.82 7.40 4.47 実測値 72.56 7.44 4.33 IR(KBr):νCO 1710,1645cm-1 NMR(CDCl3) δ:0.98(3H,d,J=6.6Hz),1.05〜1.25(2H,m),1.49
(6H,s),1.6〜1.8(3H,m),2.6〜2.8(1H,m),3.0〜3.
2(1H,m),3.95〜4.15(1H,m),4.6〜4.8(1H,m),6.87
(1H,d,J=15.4Hz),7.09(1H,d,J=8.2Hz),7.63(1H,
d,J=15.4Hz),7.77(1H,dd,J=2.2and8.2Hz),7.85(1
H,d,J=2.2Hz) 実施例4 3-(2,3−ジヒドロ−2,2−ジメチル−3−オキソ−5−
ベンゾフラニル)アクリル酸0.70gおよびペルヒドロア
ゼピン0.44mlを用い、実施例1と同様に反応させ処理し
たのち、塩化メチレン−ヘキサンより再結晶し、融点13
5〜138℃の1-〔3-(2,3−ジヒドロ−2,2−ジメチル−3
−オキソ−5−ベンゾフラニル)アクリロイル〕ペルヒ
ドロアゼピン0.84gを得た。Elemental analysis value: (as C 19 H 23 NO 3 ) C% H% N% Calculated value 72.82 7.40 4.47 Measured value 72.56 7.44 4.33 IR (KBr): ν CO 1710,1645cm −1 NMR (CDCl 3 ) δ: 0.98 ( 3H, d, J = 6.6Hz), 1.05 to 1.25 (2H, m), 1.49
(6H, s), 1.6 to 1.8 (3H, m), 2.6 to 2.8 (1H, m), 3.0 to 3.
2 (1H, m), 3.95 to 4.15 (1H, m), 4.6 to 4.8 (1H, m), 6.87
(1H, d, J = 15.4Hz), 7.09 (1H, d, J = 8.2Hz), 7.63 (1H,
d, J = 15.4Hz), 7.77 (1H, dd, J = 2.2and8.2Hz), 7.85 (1
H, d, J = 2.2 Hz) Example 4 3- (2,3-Dihydro-2,2-dimethyl-3-oxo-5-
(Benzofuranyl) acrylic acid (0.70 g) and perhydroazepine (0.44 ml) were used and treated in the same manner as in Example 1 and then recrystallized from methylene chloride-hexane to give a melting point of 13
1- [3- (2,3-dihydro-2,2-dimethyl-3 at 5 to 138 ° C
0.84 g of -oxo-5-benzofuranyl) acryloyl] perhydroazepine was obtained.
元素分析値:(C19H23NO3として) C% H% N% 計算値 72.82 7.40 4.47 実測値 72.64 7.57 4.46 IR(KBr):νCO 1710,1640cm-1 NMR(CDCl3) δ:1.49(6H,s),1.55〜1.85(8H,m),3.55〜3.7(4H,
m),6.83(1H,d,J=15.4Hz),7.09(1H,d,J=8.8Hz),
7.69(1H,d,J=15.4Hz),7.77(1H,dd,J=1.7and8.8H
z),7.86(1H,d,J=1.7Hz) 実施例5 3-(2,3−ジヒドロ−2,2−ジメチル−3−オキソ−5−
ベンゾフラニル)アクリル酸1.10gおよびモルホリン0.6
3mlを用い、実施例1と同様に反応させ処理したのち、
塩化メチレン−ヘキサンより再結晶し、融点208〜209℃
の4-〔3-(2,3−ジヒドロ−2,2−ジメチル−3−オキソ
−5−ベンゾフラニル)アクリロイル〕モルホリン0.97
gを得た。Elemental analysis value: (as C 19 H 23 NO 3 ) C% H% N% Calculated value 72.82 7.40 4.47 Measured value 72.64 7.57 4.46 IR (KBr): ν CO 1710,1640cm −1 NMR (CDCl 3 ) δ: 1.49 ( 6H, s), 1.55 ~ 1.85 (8H, m), 3.55 ~ 3.7 (4H,
m), 6.83 (1H, d, J = 15.4Hz), 7.09 (1H, d, J = 8.8Hz),
7.69 (1H, d, J = 15.4Hz), 7.77 (1H, dd, J = 1.7and8.8H
z), 7.86 (1H, d, J = 1.7Hz) Example 5 3- (2,3-Dihydro-2,2-dimethyl-3-oxo-5-
Benzofuranyl) acrylic acid 1.10 g and morpholine 0.6
After using 3 ml of the same reaction and treatment as in Example 1,
Recrystallized from methylene chloride-hexane, melting point 208-209 ° C
4- [3- (2,3-dihydro-2,2-dimethyl-3-oxo-5-benzofuranyl) acryloyl] morpholine 0.97
got g.
元素分析値:(C17H19NO4として) C% H% N% 計算値 67.76 6.35 4.65 実測値 67.45 6.36 4.55 IR(KBr):νco 1705,1645cm-1 NMR(CDCl3) δ:1.49(6H,s),3.6〜3.8(8H,m),6.80(1H,d,J=15.
4Hz),7.10(1H,d,J=8.8Hz),7.70(1H,d,J=15.4H
z),7.77(1H,dd,J=2.2and8.8Hz),7.85(1H,d,J=2.2
Hz) 実施例6 3-(2,3−ジヒドロ−2,2−ジメチル−3−オキソ−5−
ベンゾフラニル)アクリル酸0.50gとジエチルアミン0.3
4mlを用い、実施例1と同様に反応させ処理したのち、
塩化メチレン−ヘキサンより再結晶し、融点115〜118℃
のN,N−ジエチル−3-(2,3−ジヒドロ−2,2−ジメチル
−3−オキソ−5−ベンゾフラニル)アクリルアミド0.
41gを得た。Elemental analysis value: (as C 17 H 19 NO 4 ) C% H% N% Calculated value 67.76 6.35 4.65 Measured value 67.45 6.36 4.55 IR (KBr): νco 1705,1645cm -1 NMR (CDCl 3 ) δ: 1.49 (6H , s), 3.6 to 3.8 (8H, m), 6.80 (1H, d, J = 15.
4Hz), 7.10 (1H, d, J = 8.8Hz), 7.70 (1H, d, J = 15.4H)
z), 7.77 (1H, dd, J = 2.2and8.8Hz), 7.85 (1H, d, J = 2.2)
Hz) Example 6 3- (2,3-Dihydro-2,2-dimethyl-3-oxo-5-
Benzofuranyl) acrylic acid 0.50 g and diethylamine 0.3
After using 4 ml of the same reaction and treatment as in Example 1,
Recrystallized from methylene chloride-hexane, melting point 115-118 ° C
N, N-diethyl-3- (2,3-dihydro-2,2-dimethyl-3-oxo-5-benzofuranyl) acrylamide.
41g was obtained.
元素分析値:(C17H21NO3として) C% H% N% 計算値 71.06 7.37 4.87 実測値 71.07 7.58 4.64 IR(KBr):νCO 1710,1645cm-1 NMR(CDCl3) δ:1.15〜1.35(6H,m),1.49(6H,s),3.4〜3.55(4H,
m),6.79(1H,d,J=15.4Hz),7.09(1H,d,J=8.8Hz),
7.70(1H,d,J=15.4Hz),7.77(1H,dd,J=1.7and8.8H
z),7.86(1H,d,J=1.7Hz) 実施例7 3-〔2,3−ジヒドロ−2,2−ジメチル−3−オキソ−5−
ベンゾフラニル)アクリル酸0.30gおよび1-(3−アミ
ノプロピル)−2−ピロリジノン0.20mlを用い、実施例
1と同様に反応させ処理したのち、シリカゲルフラッシ
ュカラムクロマトグラフィー(溶出溶媒:クロロホルム
/エタノール=50/1)で精製し、融点155〜159℃の3-
(2,3−ジヒドロ−2,2−ジメチル−3−オキソ−5−ベ
ンゾフラニル)−N−〔3-(2−オキソ−1−ピロリジ
ニル)プロピル〕アクリルアミド0.43gを得た。Elemental analysis value: (as C 17 H 21 NO 3 ) C% H% N% Calculated value 71.06 7.37 4.87 Measured value 71.07 7.58 4.64 IR (KBr): ν CO 1710,1645cm −1 NMR (CDCl 3 ) δ: 1.15〜 1.35 (6H, m), 1.49 (6H, s), 3.4 ~ 3.55 (4H,
m), 6.79 (1H, d, J = 15.4Hz), 7.09 (1H, d, J = 8.8Hz),
7.70 (1H, d, J = 15.4Hz), 7.77 (1H, dd, J = 1.7and8.8H
z), 7.86 (1H, d, J = 1.7Hz) Example 7 3- [2,3-dihydro-2,2-dimethyl-3-oxo-5-
Benzofuranyl) acrylic acid (0.30 g) and 1- (3-aminopropyl) -2-pyrrolidinone (0.20 ml) were used and treated in the same manner as in Example 1 and then treated with silica gel flash column chromatography (eluting solvent: chloroform / ethanol = 50). / 1), melting point 155-159 ℃ 3-
0.43 g of (2,3-dihydro-2,2-dimethyl-3-oxo-5-benzofuranyl) -N- [3- (2-oxo-1-pyrrolidinyl) propyl] acrylamide was obtained.
元素分析値:(C20H24N2O4として) C% H% N% 計算値 67.40 6.79 7.86 実測値 67.28 6.75 7.58 IR(KBr):νNH 3260cm-1 νCO 1720,1665cm-1 NMR(CDCl3) δ:1.48(6H,s),1.65〜1.85(2H,m),2.07(2H,quint,
J=7.7Hz),2.45(2H,t,J=7.7Hz),3.25〜3.5(6H,
m),6.41(1H,d,J=15.4Hz),7.07(1H,d,J=7.1Hz),
7.10(1H,br-s),7.60(1H,d,J=15.4Hz),7.79(1H,d,
J=2.2Hz),7.81(1H,dd,J=2.2and7.1Hz) 実施例8 3-(2,3−ジヒドロ−2,2−ジメチル−3−オキソ−5−
ベンゾフラニル)アクリル酸0.20gおよび2−アミノメ
チルピリジン0.13mlを用い、実施例1と同様に反応させ
ほぼ同様に処理したのち、塩化メチレン−ジエチルエー
テルより再結晶し、融点124〜126℃の3-(2,3−ジヒド
ロ−2,2−ジメチル−3−オキソ−5−ベンゾフラニ
ル)−N-(2−ピリジルメチル)アクリルアミド0.27g
を得た。Elemental analysis value: (as C 20 H 24 N 2 O 4 ) C% H% N% Calculated value 67.40 6.79 7.86 Measured value 67.28 6.75 7.58 IR (KBr): ν NH 3260cm −1 ν CO 1720,1665cm −1 NMR ( CDCl 3 ) δ: 1.48 (6H, s), 1.65 ~ 1.85 (2H, m), 2.07 (2H, quint,
J = 7.7Hz), 2.45 (2H, t, J = 7.7Hz), 3.25 to 3.5 (6H,
m), 6.41 (1H, d, J = 15.4Hz), 7.07 (1H, d, J = 7.1Hz),
7.10 (1H, br-s), 7.60 (1H, d, J = 15.4Hz), 7.79 (1H, d,
J = 2.2Hz), 7.81 (1H, dd, J = 2.2and7.1Hz) Example 8 3- (2,3-Dihydro-2,2-dimethyl-3-oxo-5-
Benzofuranyl) acrylic acid (0.20 g) and 2-aminomethylpyridine (0.13 ml) were reacted in the same manner as in Example 1 and treated in substantially the same manner, followed by recrystallization from methylene chloride-diethyl ether to give 3- (mp) 124-126 ° C. (2,3-Dihydro-2,2-dimethyl-3-oxo-5-benzofuranyl) -N- (2-pyridylmethyl) acrylamide 0.27 g
Got
元素分析値:(C19H18N2O3として) C% H% N% 計算値 70.79 5.63 8.69 実測値 70.57 5.60 8.70 IR(KBr):νNH 3225cm-1 νCO 1705,1665,1650cm-1 NMR(DMSO-d6) δ:1.42(6H,s),4.50(2H,d,J=6.0Hz),6.75(1H,d,J
=15.9Hz),7.25〜7.4(3H,m),7.53(1H,d,J=15.9H
z),7.77(1H,dt,J=1.7and7.7Hz),7.85(1H,d,J=1.7
Hz),7.99(1H,dd,J=1.7and8.8Hz),8.52(1H,dd,J=
1.7and3.8Hz),8.63(1H,t,J=6.0Hz) 実施例9 3-(2,3−ジヒドロ−2,2−ジメチル−3−オキソ−5−
ベンゾフラニル)アクリル酸0.20gおよび3−アミノメ
チルピリジン0.11mlを用い、実施例1と同様に反応させ
ほぼ同様に処理したのち、塩化メチレン−ヘキサンより
再結晶し、融点152〜155℃に3-(2,3−ジヒドロ−2,2−
シメチル−3−オキソ−5−ベンゾフラニル)−N-(3
−ピリジルメチル)アクリルアミド0.25gを得た。Elemental analysis value: (as C 19 H 18 N 2 O 3 ) C% H% N% Calculated value 70.79 5.63 8.69 Measured value 70.57 5.60 8.70 IR (KBr): ν NH 3225cm -1 ν CO 1705,1665,1650cm -1 NMR (DMSO-d 6 ) δ: 1.42 (6H, s), 4.50 (2H, d, J = 6.0Hz), 6.75 (1H, d, J
= 15.9Hz), 7.25 to 7.4 (3H, m), 7.53 (1H, d, J = 15.9H
z), 7.77 (1H, dt, J = 1.7 and 7.7Hz), 7.85 (1H, d, J = 1.7)
Hz), 7.99 (1H, dd, J = 1.7and8.8Hz), 8.52 (1H, dd, J =
1.7 and 3.8 Hz), 8.63 (1H, t, J = 6.0 Hz) Example 9 3- (2,3-dihydro-2,2-dimethyl-3-oxo-5-
Benzofuranyl) acrylic acid (0.20 g) and 3-aminomethylpyridine (0.11 ml) were reacted in the same manner as in Example 1 and treated in substantially the same manner, and then recrystallized from methylene chloride-hexane to give 3- ( 2,3-dihydro-2,2-
Cimethyl-3-oxo-5-benzofuranyl) -N- (3
0.25 g of -pyridylmethyl) acrylamide was obtained.
元素分析値:(C19H18N2O3として) C% H% N% 計算値 70.79 5.63 8.69 実測値 70.70 5.62 8.60 IR(KBr):νNH 3300cm-1 νCO 1710,1650cm-1 NMR(CDCl3) δ:1.48(6H,s),4.61(2H,d,J=6.1Hz),6.40(1H,d,J
=15.4Hz),6.45(1H,br-s),7.08(1H,d,J=8.8Hz),
7.31(1H,dd,J=5.0and7.7Hz),7.67(1H,d,J=15.4H
z),7.7〜7.85(3H,m),8.53(1H,d,J=5.0Hz),8.61
(1H,s) 実施例10 3-(2,3−ジヒドロ−2,2−ジメチル−3−オキソ−5−
ベンゾフラニル)−2−メチルアクリル酸0.30gおよび
ピペリジン0.18mlを用い、実施例1と同様に反応させ処
理したのち、ジエチルエーテル−ヘキサンより再結晶
し、融点130〜132℃の3-〔3-(2,3−ジヒドロ−2,2−ジ
メチル−3−オキソ−5−ベンゾフラニル)−2−メチ
ルアクリロイル〕ピペリジン0.33gを得た。Elemental analysis value: (as C 19 H 18 N 2 O 3 ) C% H% N% Calculated value 70.79 5.63 8.69 Measured value 70.70 5.62 8.60 IR (KBr): ν NH 3300cm −1 ν CO 1710,1650cm −1 NMR ( CDCl 3 ) δ: 1.48 (6H, s), 4.61 (2H, d, J = 6.1Hz), 6.40 (1H, d, J
= 15.4Hz), 6.45 (1H, br-s), 7.08 (1H, d, J = 8.8Hz),
7.31 (1H, dd, J = 5.0 and 7.7Hz), 7.67 (1H, d, J = 15.4H)
z), 7.7 to 7.85 (3H, m), 8.53 (1H, d, J = 5.0Hz), 8.61
(1H, s) Example 10 3- (2,3-Dihydro-2,2-dimethyl-3-oxo-5-
Benzofuranyl) -2-methylacrylic acid (0.30 g) and piperidine (0.18 ml) were reacted and treated in the same manner as in Example 1 and then recrystallized from diethyl ether-hexane to give 3- [3- (having a melting point of 130 to 132 ° C. 0.33 g of 2,3-dihydro-2,2-dimethyl-3-oxo-5-benzofuranyl) -2-methylacryloyl] piperidine was obtained.
元素分析値:(C19H23NO3として) C% H% N% 計算値 72.82 7.40 4.47 実測値 72.78 7.45 4.61 IR(KBr):νCO 1715,1635cm-1 NMR(CDCl3) δ:1.48(6H,s),1.5〜1.75(6H,m),2.09(3H,d,J=1.
7Hz),3.45〜3.65(4H,m),6.48(1H,br-s),7.08(1H,
d,J=8.8Hz),7.57(1H,dd,J=1.7and8.8Hz),7.61(1
H,d,J=1.7Hz) 実施例11 3-(2,3−ジヒドロ−2,2−ジメチル−3−オキソ−6−
ベンゾフラニル)アクリル酸0.22gおよびピペリジン0.1
5mlを用い、実施例1と同様に反応させ処理したのち、
塩化メチレン−ジエチルエーテルより再結晶し、融点13
5〜138℃の1-〔3-(2,3−ジヒドロ−2,2−ジメチル−3
−オキソ−6−ベンゾフラニル)アクリロイル〕ピペリ
ジン0.21gを得た。Elemental analysis value: (as C 19 H 23 NO 3 ) C% H% N% Calculated value 72.82 7.40 4.47 Measured value 72.78 7.45 4.61 IR (KBr): ν CO 1715,1635 cm −1 NMR (CDCl 3 ) δ: 1.48 ( 6H, s), 1.5 to 1.75 (6H, m), 2.09 (3H, d, J = 1.
7Hz), 3.45 to 3.65 (4H, m), 6.48 (1H, br-s), 7.08 (1H,
d, J = 8.8Hz), 7.57 (1H, dd, J = 1.7and8.8Hz), 7.61 (1
H, d, J = 1.7 Hz) Example 11 3- (2,3-dihydro-2,2-dimethyl-3-oxo-6-
Benzofuranyl) acrylic acid 0.22 g and piperidine 0.1
After reacting and treating in the same manner as in Example 1 using 5 ml,
Recrystallized from methylene chloride-diethyl ether, melting point 13
1- [3- (2,3-dihydro-2,2-dimethyl-3 at 5 to 138 ° C
0.21 g of -oxo-6-benzofuranyl) acryloyl] piperidine was obtained.
元素分析値:(C18H21NO3として) C% H% N% 計算値 72.22 7.07 4.68 実測値 72.10 7.17 4.73 IR(KBr):νCO 1710,1640cm-1 NMR(CDCl3) δ:1.47(6H,s),1.55〜1.75(6H,m),3.55〜3.75(4H,
m),7.02(1H,d,J=15.4Hz),7.17(1H,d,J=1.1Hz),
7.22(1H,dd,J=1.1and8.2Hz),762(1H,d,J=15.4H
z),7.65(1H,d,J=8.2Hz) 実施例12 3-(2,3−ジヒドロ−2,2−ジメチル−3−オキソ−7−
ベンゾフラニル)アクリル酸0.43gおよびピペリジン0.2
7mlを用い、実施例1と同様に反応させ処理したのち、
エタノール−ヘキサンより再結晶し、融点158〜159℃の
1-〔3-(2,3−ジヒドロ−2,2−ジメチル−3−オキソ−
7−ベンゾフラニル)アクリロイル〕ピペリジン0.40g
を得た。Elemental analysis: (C 18 as H 21 NO 3) C% H % N% Calculated 72.22 7.07 4.68 Found 72.10 7.17 4.73 IR (KBr): ν CO 1710,1640cm -1 NMR (CDCl 3) δ: 1.47 ( 6H, s), 1.55 to 1.75 (6H, m), 3.55 to 3.75 (4H,
m), 7.02 (1H, d, J = 15.4Hz), 7.17 (1H, d, J = 1.1Hz),
7.22 (1H, dd, J = 1.1and8.2Hz), 762 (1H, d, J = 15.4H)
z), 7.65 (1H, d, J = 8.2Hz) Example 12 3- (2,3-Dihydro-2,2-dimethyl-3-oxo-7-
Benzofuranyl) acrylic acid 0.43 g and piperidine 0.2
After using 7 ml of the same reaction and treatment as in Example 1,
Recrystallized from ethanol-hexane, melting point 158-159 ℃
1- [3- (2,3-dihydro-2,2-dimethyl-3-oxo-
7-benzofuranyl) acryloyl] piperidine 0.40 g
Got
元素分析値:(C18H21NO3として) C% H% N% 計算値 72.22 7.07 4.68 実測値 72.12 7.12 4.67 IR(KBr):νCO 1715,1645cm-1 NMI(CDCl3) δ:1.51(6H,s),1.55〜1.8(6H,m),3.5〜3.75(4H,
m),7.09(1H,t,J=7.1Hz),7.30(1H,d,J=15.4Hz),
7.63(1H,dd,J=1.7and7.1Hz),7.68(1H,d,J=15.4H
z),7.71(1H,dd,J=1.7and7.1Hz) 実施例13 3-(2,3−ジヒドロ−7−メトキシ−2,2−ジメチル−3
−オキソ−5−ベンゾフラニル)アクリル酸0.28gおよ
びピペリジン0.16mlを用い、実施例1と同様に反応させ
処理したのち、ジエチルエーテルより再結晶し、融点16
7〜169℃の1-〔3-(2,3−ジヒドロ−7−メトキシ−2,2
−ジメチル−3−オキソ−5−ベンゾフラニル)アクリ
ロイル〕ピペリジン0.25gを得た。Elemental analysis: (C 18 as H 21 NO 3) C% H % N% Calculated 72.22 7.07 4.68 Found 72.12 7.12 4.67 IR (KBr): ν CO 1715,1645cm -1 NMI (CDCl 3) δ: 1.51 ( 6H, s), 1.55 ~ 1.8 (6H, m), 3.5 ~ 3.75 (4H,
m), 7.09 (1H, t, J = 7.1Hz), 7.30 (1H, d, J = 15.4Hz),
7.63 (1H, dd, J = 1.7and7.1Hz), 7.68 (1H, d, J = 15.4H)
z), 7.71 (1H, dd, J = 1.7 and 7.1Hz) Example 13 3- (2,3-dihydro-7-methoxy-2,2-dimethyl-3
-Oxo-5-benzofuranyl) acrylic acid (0.28 g) and piperidine (0.16 ml) were used and treated in the same manner as in Example 1 and then recrystallized from diethyl ether to give a melting point of 16
1- [3- (2,3-dihydro-7-methoxy-2,2 at 7-169 ° C
0.25 g of -dimethyl-3-oxo-5-benzofuranyl) acryloyl] piperidine was obtained.
元素分析値:(C19H23NO4として) C% H% N% 計算値 69.28 7.04 4.25 実測値 68.95 7.18 4.35 IR(KBr):νCO 1715,1640cm-1 NMR(CDCl3) δ:1.52(6H,s),1.55〜1.8(6H,m),3.5〜3.75(4H,
m),4.00(3H,s),6.84(1H,d,J=15.4Hz),7.21(1H,
d,J=1.7Hz),7.47(1H,d,J=1.7Hz),7.61(1H,d,J=1
5.4Hz) 実施例14 3-(2,3−ジヒドロ−6−メトキシ−2,2−ジメチル−3
−オキソ−5−ベンゾフラニル)アクリル酸0.40gおよ
びモルホリン0.20mlを用い、実施例1と同様に反応させ
処理したのち、塩化メチレン−ヘキサンより再結晶し、
融点179〜181℃の1-〔3-(2,3−ジヒドロ−6−メトキ
シ−2,2−ジメチル−3−オキソ−5−ベンゾフラニ
ル)アクリロイル〕モルホリン0.44gを得た。Elemental analysis value: (as C 19 H 23 NO 4 ) C% H% N% Calculated value 69.28 7.04 4.25 Measured value 68.95 7.18 4.35 IR (KBr): ν CO 1715,1640cm −1 NMR (CDCl 3 ) δ: 1.52 ( 6H, s), 1.55 ~ 1.8 (6H, m), 3.5 ~ 3.75 (4H,
m), 4.00 (3H, s), 6.84 (1H, d, J = 15.4Hz), 7.21 (1H,
d, J = 1.7Hz), 7.47 (1H, d, J = 1.7Hz), 7.61 (1H, d, J = 1)
5.4 Hz) Example 14 3- (2,3-Dihydro-6-methoxy-2,2-dimethyl-3
-Oxo-5-benzofuranyl) acrylic acid (0.40 g) and morpholine (0.20 ml) were used for the same reaction and treatment as in Example 1, and then recrystallized from methylene chloride-hexane.
0.44 g of 1- [3- (2,3-dihydro-6-methoxy-2,2-dimethyl-3-oxo-5-benzofuranyl) acryloyl] morpholine having a melting point of 179-181 ° C was obtained.
元素分析値:(C18H21NO5として) C% H% N% 計算値 65.24 6.39 4.23 実測値 64.94 6.40 4.12 IR(KBr):νCO 1695,1650cm-1 NMR(CDCl3) δ:1.47(6H,s),3.6〜3.8(8H,m),3.95(3H,s),6.52
(1H,s),6.84(1H,d,J=15.4Hz),7.83(1H,s),7.95
(1H,d,J=15.4Hz) 実施例15 3-(2,3−ジヒドロ−2,2−ジメチル−3−オキソ−5−
ベンゾフラニル〕アクリル酸0.50gに乾燥ベンゼン10ml
と塩化チオニル0.8mlを加え、2時間加熱還流させた。
反応液を減圧下に濃縮乾固し、この残留物の乾燥ジオキ
サン15ml溶液を、25%アンモニア水5mlとジオキサン5ml
の混液に氷冷撹拌下に滴下したのち、30分間反応させ
た。反応液を減圧下に濃縮後、水を加え塩化メチレンで
抽出し、水洗後無水硫酸マグネシウムで乾燥した。減圧
下に溶媒を留去後、残留物をエタノールより再結晶し、
融点186〜189℃の3-(2,3−ジヒドロ−2,2−ジメチル−
3−オキソ−5−ベンゾフラニル)アクリルアミド0.45
gを得た。Elemental analysis value: (as C 18 H 21 NO 5 ) C% H% N% Calculated value 65.24 6.39 4.23 Measured value 64.94 6.40 4.12 IR (KBr): ν CO 1695,1650 cm −1 NMR (CDCl 3 ) δ: 1.47 ( 6H, s), 3.6 ~ 3.8 (8H, m), 3.95 (3H, s), 6.52
(1H, s), 6.84 (1H, d, J = 15.4Hz), 7.83 (1H, s), 7.95
(1H, d, J = 15.4Hz) Example 15 3- (2,3-dihydro-2,2-dimethyl-3-oxo-5-
Benzofuranyl] acrylic acid 0.50 g to dry benzene 10 ml
And thionyl chloride (0.8 ml) were added and the mixture was heated under reflux for 2 hours.
The reaction solution was concentrated to dryness under reduced pressure, and a solution of this residue in 15 ml of dry dioxane was added to 5 ml of 25% aqueous ammonia and 5 ml of dioxane.
After being added dropwise to the mixed solution of under ice-cooling stirring, the mixture was reacted for 30 minutes. The reaction mixture was concentrated under reduced pressure, water was added, the mixture was extracted with methylene chloride, washed with water, and dried over anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure, the residue was recrystallized from ethanol,
3- (2,3-dihydro-2,2-dimethyl-
3-oxo-5-benzofuranyl) acrylamide 0.45
got g.
元素分析値:(C13H13NO3として) C% H% N% 計算値 67.52 5.67 6.06 実測値 67.69 5.67 5.80 IR(KBr):νNH 3375,3160cm-1 νCO 1705,1660cm-1 NMR(CDCl3) δ:1.48(6H,s),5.64(2H,br-s),6.41(1H,d,J=15.4
Hz),7.10(1H,d,J=8.8Hz),7.65(1H,d,J=15.4Hz),
7.77(1H,dd,J=2.2and8.8Hz),7.83(1H,d,J=2.2Hz) 実施例16 3-(2,3−ジヒドロ−2,2−ジメチル−3−オキソ−5−
ベンゾフラニル)アクリル酸0.50gおよび40%メチルア
ミン水溶液0.5mlを用い、実施例15と同様に反応させ処
理したのち、エタノール−ジエチルエーテルより再結晶
し、融点194〜197℃の3-(2,3−ジヒドロ−2,2−ジメチ
ル−3−オキソ−5−ベンゾフラニル)−N−メチルア
クリルアミド0.42gを得た。Elemental analysis value: (as C 13 H 13 NO 3 ) C% H% N% Calculated value 67.52 5.67 6.06 Measured value 67.69 5.67 5.80 IR (KBr): ν NH 3375,3160cm −1 ν CO 1705,1660cm -1 NMR ( CDCl 3 ) δ: 1.48 (6H, s), 5.64 (2H, br-s), 6.41 (1H, d, J = 15.4
Hz), 7.10 (1H, d, J = 8.8Hz), 7.65 (1H, d, J = 15.4Hz),
7.77 (1H, dd, J = 2.2and8.8Hz), 7.83 (1H, d, J = 2.2Hz) Example 16 3- (2,3-dihydro-2,2-dimethyl-3-oxo-5-
Benzofuranyl) acrylic acid (0.50 g) and 40% aqueous methylamine solution (0.5 ml) were used and treated in the same manner as in Example 15 and then recrystallized from ethanol-diethyl ether to give 3- (2,3) having a melting point of 194-197 ° C. 0.42 g of -dihydro-2,2-dimethyl-3-oxo-5-benzofuranyl) -N-methylacrylamide was obtained.
元素分析値:(C14H15NO3として) C% H% N% 計算値 68.56 6.16 5.71 実測値 68.25 6.28 5.69 IR(KBr):νNH 3250cm-1 νCO 1715,1665,1645cm-1 NMR(CDCl3) δ:1.48(6H,s),2.96(3H,d,J=4.9Hz),5.70(1H,br-
s),6.34(1H,d,J=15.4Hz),7.08(1H,d,J=8.2Hz),
7.62(1H,d,J=15.4Hz),7.75(1H,dd,J=1.7and8.2H
z),7.81(1H,d,J=1.7Hz) 実施例17 3-(2,3−ジヒドロ−2,2−ジメチル−3−オキソ−5−
ベンゾフラニル)アクリル酸0.50gおよび70%エチルア
ミン水溶液0.5mlを用い、実施例15と同様に反応させ処
理したのち、塩化メチレン−ヘキサンより再結晶し、融
点179〜181℃のN−エチル−3-(2,3−ジヒドロ−2,2−
ジメチル−3−オキソ−5−ベンゾフラニル)アクリル
アミド0.44gを得た。Elemental analysis value: (as C 14 H 15 NO 3 ) C% H% N% Calculated value 68.56 6.16 5.71 Measured value 68.25 6.28 5.69 IR (KBr): ν NH 3250cm −1 ν CO 1715,1665,1645cm −1 NMR ( CDCl 3 ) δ: 1.48 (6H, s), 2.96 (3H, d, J = 4.9Hz), 5.70 (1H, br-
s), 6.34 (1H, d, J = 15.4Hz), 7.08 (1H, d, J = 8.2Hz),
7.62 (1H, d, J = 15.4Hz), 7.75 (1H, dd, J = 1.7and8.2H
z), 7.81 (1H, d, J = 1.7Hz) Example 17 3- (2,3-Dihydro-2,2-dimethyl-3-oxo-5-
(Benzofuranyl) acrylic acid (0.50 g) and 70% aqueous ethylamine solution (0.5 ml) were used for the same reaction and treatment as in Example 15, followed by recrystallization from methylene chloride-hexane and N-ethyl-3- (mp 179-181 ° C. 2,3-dihydro-2,2-
0.44 g of dimethyl-3-oxo-5-benzofuranyl) acrylamide was obtained.
元素分析値:(C15H17NO3として) C% H% N% 計算値 69.48 6.61 5.40 実測値 69.45 6.69 5.08 IR(KBr):νNH 3320cm-1 νCO 1715,1645cm-1 NMR(CDCl3) δ:1.22(3H,t,J=7.1Hz),1.48(6H,s),3.44(2H,dq,
J=5.5and7.1Hz),5.70(1H,br-s),6.33(1H,d,J=15.
4Hz),7.07(1H,d,J=8.8Hz),7.62(1H,d,J=15.4H
z),7.75(1H,dd,J=1.7and8.8Hz),7.80(1H,d,J=1.7
Hz) 実施例18 3-(2,3−ジヒドロ−2,2−ジメチル−3−オキソ−5−
ベンゾフラニル)アクリル酸0.50gおよび50%ジメチル
アミン水溶液0.6mlを用い、実施例15と同様に反応させ
処理したのち、塩化メチレン−ヘキサンより再結晶し、
融点158〜159℃の3-(2,3−ジヒドロ−2,2−ジメチル−
3−オキソ−5−ベンゾフラニル)−N,N−ジメチルア
クリルアミド0.43gを得た。Elemental analysis value: (as C 15 H 17 NO 3 ) C% H% N% Calculated value 69.48 6.61 5.40 Measured value 69.45 6.69 5.08 IR (KBr): ν NH 3320cm −1 ν CO 1715,1645cm −1 NMR (CDCl 3 ) Δ: 1.22 (3H, t, J = 7.1Hz), 1.48 (6H, s), 3.44 (2H, dq,
J = 5.5 and 7.1Hz), 5.70 (1H, br-s), 6.33 (1H, d, J = 15.
4Hz), 7.07 (1H, d, J = 8.8Hz), 7.62 (1H, d, J = 15.4H)
z), 7.75 (1H, dd, J = 1.7and8.8Hz), 7.80 (1H, d, J = 1.7)
Hz) Example 18 3- (2,3-Dihydro-2,2-dimethyl-3-oxo-5-
Benzofuranyl) acrylic acid (0.50 g) and 50% dimethylamine aqueous solution (0.6 ml) were used and treated in the same manner as in Example 15 and then recrystallized from methylene chloride-hexane.
3- (2,3-dihydro-2,2-dimethyl-
0.43 g of 3-oxo-5-benzofuranyl) -N, N-dimethylacrylamide was obtained.
元素分析値:(C15H17NO3として) C% H% N% 計算値 69.48 6.61 5.40 実測値 69.26 6.73 5.13 IR(KBr):νCO 1705,1645cm-1 NMR(CDCl3) δ:1.49(6H,s),3.13(6H,br-s),6.85(1H,d,J=15.4
Hz),7.09(1H,d,J=8.8Hz),7.66(1H,d,J=15.4Hz),
7.77(1H,d,J=1.7and8.8Hz),7.86(1H,d,J=1.7Hz 実施例19 3-(2,3−ジヒドロ−2,2−ジメチル−3−オキソ−5−
ベンゾフラニル)アクリル酸0.30gに乾燥ベンゼン10ml
と塩化チオニル0.5mlを加え、2時間加熱還流後、反応
液を減圧下に濃縮乾固した。この残留物の乾燥ジオキサ
ン5ml溶液を、塩酸グリシンエチルエステル0.54g、炭酸
水素ナトリウム0.33g、ジオキサン3mlおよび1規定水酸
化ナトリウム水溶液3.9mlの混合物中に氷冷撹拌下に滴
下したのち、室温で30分間撹拌した。反応液を減圧下に
濃縮したのち、水を加え塩化メチレンで抽出し、希塩
酸、水、炭酸水素ナトリウム水溶液および水で順次洗っ
たのち、無水硫酸マグネシウムで乾燥した。減圧下に溶
媒を留去後、エタノールより再結晶し、融点148〜150℃
のN-〔3-(2,3−ジヒドロ−2,2−ジメチル−3−オキソ
−5−ベンゾフラニル)アクリロイル〕グリシンエチル
エステル0.24gを得た。Elemental analysis value: (as C 15 H 17 NO 3 ) C% H% N% Calculated value 69.48 6.61 5.40 Measured value 69.26 6.73 5.13 IR (KBr): ν CO 1705, 1645 cm −1 NMR (CDCl 3 ) δ: 1.49 ( 6H, s), 3.13 (6H, br-s), 6.85 (1H, d, J = 15.4
Hz), 7.09 (1H, d, J = 8.8Hz), 7.66 (1H, d, J = 15.4Hz),
7.77 (1H, d, J = 1.7 and 8.8Hz), 7.86 (1H, d, J = 1.7Hz) Example 19 3- (2,3-dihydro-2,2-dimethyl-3-oxo-5-
Benzofuranyl) acrylic acid 0.30g to dry benzene 10ml
And thionyl chloride (0.5 ml) were added and the mixture was heated under reflux for 2 hours, and the reaction mixture was concentrated to dryness under reduced pressure. A solution of this residue in 5 ml of dry dioxane was added dropwise to a mixture of 0.54 g of glycine ethyl ester hydrochloride, 0.33 g of sodium hydrogencarbonate, 3 ml of dioxane and 3.9 ml of 1N aqueous sodium hydroxide solution under ice-cooling stirring, and then at room temperature. Stir for minutes. The reaction mixture was concentrated under reduced pressure, water was added, the mixture was extracted with methylene chloride, washed successively with diluted hydrochloric acid, water, aqueous sodium hydrogen carbonate solution and water, and dried over anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure, it was recrystallized from ethanol and had a melting point of 148 to 150 ° C.
N- [3- (2,3-dihydro-2,2-dimethyl-3-oxo-5-benzofuranyl) acryloyl] glycine ethyl ester (0.24 g) was obtained.
元素分析値:(C17H19NO5として) C% H% N% 計算値 64.34 6.03 4.41 実測値 64.20 6.12 4.45 IR(KBr):νNH 3360cm-1 νCO 1735,1710,1675cm-1 NMR(CDCl3) δ:1.31(3H,t,J=7.1Hz),1.48(6H,s),4.17(2H,d,J
=5.0Hz),4.26(2H,q,J=7.1Hz),6.13(1H,br-s),6.
40(1H,d,J=15.4Hz),7.09(1H,d,J=8.8Hz),7.64(1
H,d,J=15.4Hz),7.78(1H,dd,J=1.7and8.8Hz),7.82
(1H,d,J=1.7Hz) 実施例20 1-〔5-(2−ブロモ−2−メチルプロピオニル)−4−
ヒドロキシ−2−メトキシシンナモイル〕ピペリジン1.
48gを乾燥1,2−ジメトキシエタン30mlに溶かし、ヨウ化
ナトリウム0.81gと炭酸カリウム1.30gを加え、80℃で5
時間撹拌した。反応液を減圧下に濃縮後、水を加えクロ
ロホルムで抽出し、水洗後無水硫酸マグネシウムで乾燥
した。減圧下に溶媒を留去し、残留物をシリカゲルフラ
ッシュカラムクロマトグラフィー(溶出溶媒:クロロホ
ルム/エタノール=5/1)で精製後、ジエチルエーテル
−ヘキサンより再結晶し、融点168〜170℃の1-〔3-(2,
3−ジヒドロ−6−メトキシ−2,2−ジメチル−3−オキ
ソ−5−ベンゾフラニル)アクリロイル〕ピペリジン0.
52gを得た。Elemental analysis value: (as C 17 H 19 NO 5 ) C% H% N% Calculated value 64.34 6.03 4.41 Actual value 64.20 6.12 4.45 IR (KBr): ν NH 3360cm −1 ν CO 1735,1710,1675cm −1 NMR ( CDCl 3 ) δ: 1.31 (3H, t, J = 7.1Hz), 1.48 (6H, s), 4.17 (2H, d, J
= 5.0Hz), 4.26 (2H, q, J = 7.1Hz), 6.13 (1H, br-s), 6.
40 (1H, d, J = 15.4Hz), 7.09 (1H, d, J = 8.8Hz), 7.64 (1
H, d, J = 15.4Hz), 7.78 (1H, dd, J = 1.7and8.8Hz), 7.82
(1H, d, J = 1.7Hz) Example 20 1- [5- (2-Bromo-2-methylpropionyl) -4-
Hydroxy-2-methoxycinnamoyl] piperidine 1.
Dissolve 48 g in 30 ml of dry 1,2-dimethoxyethane, add 0.81 g of sodium iodide and 1.30 g of potassium carbonate, and add 5
Stir for hours. The reaction mixture was concentrated under reduced pressure, water was added, the mixture was extracted with chloroform, washed with water, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel flash column chromatography (eluting solvent: chloroform / ethanol = 5/1) and then recrystallized from diethyl ether-hexane to give 1-melting point 168-170 ° C. 〔3- (2,
3-dihydro-6-methoxy-2,2-dimethyl-3-oxo-5-benzofuranyl) acryloyl] piperidine 0.
Got 52g.
元素分析値:(C19H23NO4として) C% H% N% 計算値 69.28 7.04 4.25 実測値 68.99 7.02 4.25 IR(KBr):νCO 1700,1640cm-1 NMR(CDCl3) δ:1.47(6H,s),1.55〜1.75(6H,m),3.5〜3.7(4H,
m),3.94(3H,s),6.51(1H,s),6.89(1H,d,J=15.4H
z),7.84(1H,s),7.90(1H,d,J=15.4Hz) 実施例21 7−ブロモ−2,2,5−トリメチル−3(2H)−ベンゾフ
ラノン1.00g、1−アクリロイルピペリジン0.55g、トリ
エチルアミン0.68ml、酢酸パラジウム18mgおよびトリス
(2−メチルフェニル)ホスフィン48mgの混合物をアル
ゴン気流中100℃で13時間加熱した。冷後希塩酸を加え
酸性としたのち、塩化メチレンで抽出し、水洗後無水硫
酸マグネシウムで乾燥した。減圧下に溶媒を留去し、残
留物をシリカゲルフラッシュカラムクロマトグラフィー
(溶出溶媒:ベンゼン/クロロホルム=1/1)で精製
後、塩化メチレン−ジエチルエーテルより再結晶し、融
点142〜144℃の1-〔3-(2,3−ジヒドロ−2,2,5−トリメ
チル−3−オキソ−7−ベンゾフラニル)アクリロイ
ル〕ピペリジン0.45gを得た。Elemental analysis value: (as C 19 H 23 NO 4 ) C% H% N% Calculated value 69.28 7.04 4.25 Measured value 68.99 7.02 4.25 IR (KBr): ν CO 1700,1640cm −1 NMR (CDCl 3 ) δ: 1.47 ( 6H, s), 1.55 to 1.75 (6H, m), 3.5 to 3.7 (4H,
m), 3.94 (3H, s), 6.51 (1H, s), 6.89 (1H, d, J = 15.4H
z), 7.84 (1H, s), 7.90 (1H, d, J = 15.4Hz) Example 21 7-Bromo-2,2,5-trimethyl-3 (2H) -benzofuranone 1.00 g, 1-acryloylpiperidine 0.55 A mixture of g, 0.68 ml of triethylamine, 18 mg of palladium acetate and 48 mg of tris (2-methylphenyl) phosphine was heated at 100 ° C for 13 hours in a stream of argon. After cooling, the mixture was acidified with diluted hydrochloric acid, extracted with methylene chloride, washed with water, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel flash column chromatography (eluting solvent: benzene / chloroform = 1/1) and then recrystallized from methylene chloride-diethyl ether, melting point 142-144 ° C. 0.45 g of-[3- (2,3-dihydro-2,2,5-trimethyl-3-oxo-7-benzofuranyl) acryloyl] piperidine was obtained.
元素分析値:(C19H23NO3として) C% H% N% 計算値 72.82 7.40 4.47 実測値 72.95 7.52 4.71 IR(KBr):νCO 1710,1640cm-1 NMR(CDCl3) δ:1.49(6H,s),1.55〜1.75(6H,m),2.36(3H,s),3,
5〜3,75(4H,m),7.28(1H,d,J=15.4Hz),7.42(1H,d,
J=1.7Hz),7.52(1H,d,J=1.7Hz),7.64(1H,d,J=15.
4Hz) 実施例22 7−ブロモ−2,3−ジヒドロ−2,2−ジメチル−3−オキ
ソ−5−ベンゾフランカルボン酸エチル0.58g、1−ア
クリロイルピペリジン0.37g、トリエチルアミン0.31m
l、酢酸パラジウム12mgおよびトリフェニルホスフィン2
8mgの混合物を実施例21と同様に反応させ処理したの
ち、シリカゲルフラッシュカラムクロマトグラブィー
(溶出溶媒:クロロホルム/ベンゼン=2/1)で精製
後、塩化メチレン−ジエチルエーテルより再結晶し、融
点144〜146℃の1-〔3-(5−エトキシカルボニル−2,3
−ジヒドロ−2,2−ジメチル−3−オキソ−7−ベンゾ
フラニル)アクリロイル〕ピペリジン0.31gを得た。Elemental analysis value: (as C 19 H 23 NO 3 ) C% H% N% Calculated value 72.82 7.40 4.47 Measured value 72.95 7.52 4.71 IR (KBr): ν CO 1710,1640cm −1 NMR (CDCl 3 ) δ: 1.49 ( 6H, s), 1.55 to 1.75 (6H, m), 2.36 (3H, s), 3,
5 to 3,75 (4H, m), 7.28 (1H, d, J = 15.4Hz), 7.42 (1H, d,
J = 1.7Hz), 7.52 (1H, d, J = 1.7Hz), 7.64 (1H, d, J = 15.
4 Hz) Example 22 Ethyl 7-bromo-2,3-dihydro-2,2-dimethyl-3-oxo-5-benzofurancarboxylate 0.58 g, 1-acryloylpiperidine 0.37 g, triethylamine 0.31 m
l, palladium acetate 12 mg and triphenylphosphine 2
8 mg of the mixture was reacted and treated in the same manner as in Example 21, purified by silica gel flash column chromatography (eluting solvent: chloroform / benzene = 2/1), and then recrystallized from methylene chloride-diethyl ether to give a melting point of 144- 1- [3- (5-ethoxycarbonyl-2,3 at 146 ° C
0.31 g of -dihydro-2,2-dimethyl-3-oxo-7-benzofuranyl) acryloyl] piperidine was obtained.
元素分析値:(C21H25NO5として) C% H% N% 計算値 67.91 6.78 3.77 実測値 67.72 6.79 3.71 IR(KBr):νCO 1725,1710,1640cm-1 NMR(CDCl3) δ:1.41(3H,t,J=7.1Hz),1.53(6H,s),1.55〜1.75
(6H,m),3.55〜3.75(4H,m),4.40(2H,q,J=7.1Hz),
7.28(1H,d,J=15.4Hz),7.73(1H,d,J=15.4Hz),8.33
(1H,d,J=1.7Hz),8.44(1H,d,J=1.7Hz) 実施例23 5−ホルミル−2,2−ジメチル−7−ニトロ−3(2H)
−ベンゾフラノン2.15gとモルホリノカルボニル酢酸3.1
7gを乾燥ピリジン15mlに溶かし、ピペリジン1mlを加
え、60℃で16時間撹拌後、2時間加熱還流させた。反応
液を減圧化に濃縮したのち、塩酸で酸性とし、酢酸エチ
ルで抽出したのち、炭酸水素ナトリウム水溶液および水
で洗い、無水硫酸マグネシウムで乾燥した。減圧下に溶
媒を留去したのち、残留物をシリカゲルフラッシュカラ
ムクロマトグラフィー(溶出溶媒:クロロホルム/エタ
ノール=100/1)で精製後、クロロホルム−ジエチルエ
ーテルより再結晶し、融点196〜199℃の4-〔3-(2,3−
ジヒドロ−2,2−ジメチル−7−ニトロ−3−オキソ−
5−ベンゾフラニル)アクリロイル〕モルホリン1.73g
を得た。Elemental analysis value: (as C 21 H 25 NO 5 ) C% H% N% Calculated value 67.91 6.78 3.77 Measured value 67.72 6.79 3.71 IR (KBr): ν CO 1725,1710,1640cm −1 NMR (CDCl 3 ) δ: 1.41 (3H, t, J = 7.1Hz), 1.53 (6H, s), 1.55 to 1.75
(6H, m), 3.55 to 3.75 (4H, m), 4.40 (2H, q, J = 7.1Hz),
7.28 (1H, d, J = 15.4Hz), 7.73 (1H, d, J = 15.4Hz), 8.33
(1H, d, J = 1.7Hz), 8.44 (1H, d, J = 1.7Hz) Example 23 5-Formyl-2,2-dimethyl-7-nitro-3 (2H)
-Benzofuranone 2.15 g and morpholino carbonyl acetic acid 3.1
7 g was dissolved in 15 ml of dry pyridine, 1 ml of piperidine was added, and the mixture was stirred at 60 ° C. for 16 hours and then heated under reflux for 2 hours. The reaction mixture was concentrated under reduced pressure, acidified with hydrochloric acid, extracted with ethyl acetate, washed with aqueous sodium hydrogen carbonate solution and water, and dried over anhydrous magnesium sulfate. After evaporating the solvent under reduced pressure, the residue was purified by silica gel flash column chromatography (eluting solvent: chloroform / ethanol = 100/1) and then recrystallized from chloroform-diethyl ether to give a mp of 196-199 ° C. -[3- (2,3-
Dihydro-2,2-dimethyl-7-nitro-3-oxo-
5-benzofuranyl) acryloyl] morpholine 1.73 g
Got
元素分析値:(C17H18N2O6として) C% H% N% 計算値 58,96 5.24 8.09 実測値 58.71 5.21 8.13 IR(KBr):νCO 1725,1650cm-1 νNO2 1525cm-1 NMR(CDCl3) δ:1.60(6H,s),3.6〜3.8(8H,m),6.92(1H,d,J=15.
4Hz),7.71(1H,d,J=15.4Hz),8.10(1H,d,J=1.7H
z),8.58(1H,d,J=1.7Hz) 実施例24 4-〔3-(2,3−ジヒドロ−2,2−ジメチル−7−ニトロ−
3−オキソ−5−ベンゾフラニル)アクリロイル〕モル
ホリン1.38gのアセトン20ml懸濁液に、塩化アンモニウ
ム0.43gの水12ml溶液を加え、50℃で撹拌下に亜鉛末1.5
2gを少量ずつ加えたのち、70℃で1時間撹拌した。不溶
物をろ去し、ろ液を減圧下に濃縮後、水を加えクロロホ
ルムで抽出し、水洗後無水硫酸マグネシウムで乾燥し
た。減圧下に溶媒を留去後、残留物を塩化メチレン−ジ
エチルエーテルより再結晶し、融点252〜255℃の4-〔3-
(7−アミノ−2,3−ジヒドロ−2,2−ジメチル−3−オ
キソ−5−ベンゾフラニル)アクリロイル〕モルホリン
1.10gを得た。Elemental analysis value: (as C 17 H 18 N 2 O 6 ) C% H% N% Calculated value 58,96 5.24 8.09 Measured value 58.71 5.21 8.13 IR (KBr): ν CO 1725,1650cm -1 νNO 2 1525cm -1 NMR (CDCl 3 ) δ: 1.60 (6H, s), 3.6-3.8 (8H, m), 6.92 (1H, d, J = 15.
4Hz), 7.71 (1H, d, J = 15.4Hz), 8.10 (1H, d, J = 1.7H
z), 8.58 (1H, d, J = 1.7Hz) Example 24 4- [3- (2,3-dihydro-2,2-dimethyl-7-nitro-
To a suspension of 1.38 g of 3-oxo-5-benzofuranyl) acryloyl] morpholine in 20 ml of acetone, a solution of 0.43 g of ammonium chloride in 12 ml of water was added, and zinc powder was added under stirring at 50 ° C to give 1.5 parts of zinc powder.
After adding 2g little by little, it stirred at 70 degreeC for 1 hour. The insoluble material was removed by filtration, the filtrate was concentrated under reduced pressure, water was added, the mixture was extracted with chloroform, washed with water, and dried over anhydrous magnesium sulfate. After evaporating the solvent under reduced pressure, the residue was recrystallized from methylene chloride-diethyl ether to give 4- [3-
(7-Amino-2,3-dihydro-2,2-dimethyl-3-oxo-5-benzofuranyl) acryloyl] morpholine
1.10 g was obtained.
元素分析値:(C17H20N2O4として) C% H% N% 計算値 64.54 6.37 8.86 実測値 64.82 6.59 8.59 IR(KBr):νNH 3470,3350cm-1 νCO 1695,1645cm-1 NMR(CDCl3) δ:1.49(6H,s),2.8(2H,br),3.6〜3.8(8H,m),6.75
(1H,d,J=15.4Hz),7.10(1H,d,J=1.1Hz),7.29(1H,
d,J=1.1Hz),7.62(1H,d,J=15.4Hz) 実施例25 4-〔3-(7−アミノ−2,3−ジヒドロ−2,2−ジメチル−
3−オキソ−5−ベンゾフラニル)アクリロイル〕モル
ホリン0.68gの乾燥ベンゼン8ml懸濁液に、無水酢酸1.1m
lおよび酢酸ナトリウム0.22gを加えたのち、4時間加熱
還流させた。反応液を希塩酸、水、炭酸水素ナトリウム
水溶液および水で順次洗ったのち、無水硫酸マグネシウ
ムで乾燥した。減圧下に溶媒を留去し、残留物を酢酸エ
チル−ジエチルエーテルより再結晶し、融点190〜192℃
の4-〔3-(7−アセチルアミノ−2,3−ジヒドロ−2,2−
ジメチル−3−オキソ−5−ベンゾフラニル)アクリロ
イル〕モルホリン0.52gを得た。Elemental analysis: (C 17 H 20 as N 2 O 4) C% H % N% Calculated 64.54 6.37 8.86 Found 64.82 6.59 8.59 IR (KBr): ν NH 3470,3350cm -1 ν CO 1695,1645cm -1 NMR (CDCl 3 ) δ: 1.49 (6H, s), 2.8 (2H, br), 3.6 to 3.8 (8H, m), 6.75
(1H, d, J = 15.4Hz), 7.10 (1H, d, J = 1.1Hz), 7.29 (1H,
d, J = 1.1 Hz), 7.62 (1H, d, J = 15.4 Hz) Example 25 4- [3- (7-amino-2,3-dihydro-2,2-dimethyl-
3-oxo-5-benzofuranyl) acryloyl] morpholine 0.68 g in dry benzene 8 ml suspension, acetic anhydride 1.1 m
1 and 0.22 g of sodium acetate were added, and the mixture was heated under reflux for 4 hours. The reaction solution was washed successively with diluted hydrochloric acid, water, an aqueous sodium hydrogen carbonate solution and water, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, the residue was recrystallized from ethyl acetate-diethyl ether, and the melting point was 190 to 192 ° C.
4- [3- (7-acetylamino-2,3-dihydro-2,2-
0.52 g of dimethyl-3-oxo-5-benzofuranyl) acryloyl] morpholine was obtained.
元素分析値:(C19H22N2O5として) C% H% N% 計算値 63.68 6.19 7.82 実測値 63.36 6.42 7.60 IR(KBr):νNH 3250cm-1 νCO 1720,1660,1645cm-1 NMR(CDCl3) δ:1.51(6H,s),2.29(3H,s),3.6〜3.8(8H,m),6.82
(1H,d,J=15.4Hz),7.46(1H,br-s),7.50(1H,d,J=
1.1Hz),7.69(1H,d,J=15.4Hz),8.87(1H,d,J=1.1H
z)Elemental analysis value: (as C 19 H 22 N 2 O 5 ) C% H% N% Calculated value 63.68 6.19 7.82 Actual value 63.36 6.42 7.60 IR (KBr): ν NH 3250cm -1 ν CO 1720,1660,1645cm -1 NMR (CDCl 3 ) δ: 1.51 (6H, s), 2.29 (3H, s), 3.6-3.8 (8H, m), 6.82
(1H, d, J = 15.4Hz), 7.46 (1H, br-s), 7.50 (1H, d, J =
1.1Hz), 7.69 (1H, d, J = 15.4Hz), 8.87 (1H, d, J = 1.1H
z)
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 31/40 31/44 31/445 31/535 31/55 審査官 星野 紹英 (56)参考文献 特開 平1−246271(JP,A) 薬学雑誌,109(10),718−36(1989) 薬学雑誌,109(10),737−48(1989)─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Office reference number FI Technical indication location A61K 31/40 31/44 31/445 31/535 31/55 Examiner Shoei Hoshino (56) Reference References JP-A-1-246271 (JP, A) Pharmaceutical Journal, 109 (10), 718-36 (1989) Pharmaceutical Journal, 109 (10), 737-48 (1989)
Claims (4)
れぞれ水素原子または置換基として低級アルコキシカル
ボニル基、2−オキソ−1−ピロリジニル基またはピリ
ジル基を有することもある低級アルキル基であるか、あ
るいは−NR1R2が一体となって1−ピロリジニル基、ピ
ペリジノ基、4−メチルピペリジノ基、モルホリノ基ま
たは1−ペルヒドロアゼピニル基を形成するものであ
り、R3およびR4は水素原子または低級アルキル基であ
り、Yは水素原子、ニトロ基、アミノ基、低級アシルア
ミノ基、低級アルキル基、低級アルコキシ基または低級
アルコキシカルボニル基である)で表されるジヒドロベ
ンゾフラノン誘導体。1. A general formula (In the formula, R 1 and R 2 may be the same or different and each is a hydrogen atom or a lower alkoxycarbonyl group as a substituent, a 2-oxo-1-pyrrolidinyl group or a lower alkyl group which may have a pyridyl group. Or N-R 1 R 2 together form a 1-pyrrolidinyl group, a piperidino group, a 4-methylpiperidino group, a morpholino group or a 1-perhydroazepinyl group, and R 3 and R 4 Is a hydrogen atom or a lower alkyl group, and Y is a hydrogen atom, a nitro group, an amino group, a lower acylamino group, a lower alkyl group, a lower alkoxy group or a lower alkoxycarbonyl group).
つ)で表される請求項第1項記載のジヒドロベンゾフラ
ノン誘導体。2. General formula The dihydrobenzofuranone derivative according to claim 1, wherein R 1 , R 2 , R 3 , R 4 and Y in the formula have the same meanings as described above.
で表される請求項第2項記載のジヒドロベンゾフラノン
誘導体。3. General formula (In the formula, R 1 , R 2 , R 3 and R 4 have the same meanings as described above.)
The dihydrobenzofuranone derivative according to claim 2, which is represented by:
る請求項第3項記載のジヒドロベンゾフラノン誘導体。4. A general formula The dihydrobenzofuranone derivative according to claim 3, wherein R 3 and R 4 have the same meanings as described above.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7413188A JPH07121933B2 (en) | 1988-03-28 | 1988-03-28 | Dihydrobenzofuranone derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7413188A JPH07121933B2 (en) | 1988-03-28 | 1988-03-28 | Dihydrobenzofuranone derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH01246272A JPH01246272A (en) | 1989-10-02 |
| JPH07121933B2 true JPH07121933B2 (en) | 1995-12-25 |
Family
ID=13538329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7413188A Expired - Lifetime JPH07121933B2 (en) | 1988-03-28 | 1988-03-28 | Dihydrobenzofuranone derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH07121933B2 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5674891A (en) * | 1994-07-27 | 1997-10-07 | The Procter & Gamble Company | Dihydrobenzothiophene compounds useful as anti-inflammatory agents |
| US5684002A (en) * | 1994-09-07 | 1997-11-04 | The Procter & Gamble Company | Dihydorbenzofuran and related compounds useful as anti-inflammatory agents |
| US5672620A (en) * | 1996-02-01 | 1997-09-30 | The Procter & Gamble Company | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| US5684031A (en) * | 1996-02-01 | 1997-11-04 | The Procter & Gamble Company | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| WO1998037070A1 (en) * | 1997-02-21 | 1998-08-27 | Takeda Chemical Industries, Ltd. | Fused ring compounds, process for producing the same and use thereof |
| DE60125026T2 (en) | 2000-03-23 | 2007-06-28 | Takeda Pharmaceutical Co. Ltd. | FLUOROISOCHINOLINE DERIVATIVES, METHOD FOR THEIR PREPARATION AND THEIR USE |
| DE10259619A1 (en) * | 2002-12-18 | 2004-07-08 | Metagen Pharmaceuticals Gmbh | Use of a TRPM8 activating substance for tumor treatment |
-
1988
- 1988-03-28 JP JP7413188A patent/JPH07121933B2/en not_active Expired - Lifetime
Non-Patent Citations (2)
| Title |
|---|
| 薬学雑誌,109(10),718−36(1989) |
| 薬学雑誌,109(10),737−48(1989) |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH01246272A (en) | 1989-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2142946C1 (en) | Derivatives of pyrazole and pharmaceutical composition containing thereof | |
| WO2003084930A1 (en) | Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives | |
| AU2019233698A1 (en) | Novel calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferatory agents | |
| JPH05504967A (en) | N-phenylglycinamide derivatives, their production and pharmaceuticals containing them | |
| JPS62175461A (en) | Cholecystokinin (cck) antagonist | |
| JPH07121933B2 (en) | Dihydrobenzofuranone derivative | |
| JP3647451B2 (en) | Benzolactam derivatives | |
| JPH0222059B2 (en) | ||
| JPWO1995009160A1 (en) | benzolactam derivatives | |
| JPH0482146B2 (en) | ||
| JPH0637447B2 (en) | New amide compound | |
| JPH06220029A (en) | 1,4-benzoxazine derivative | |
| TW201206910A (en) | Substituted N-heterocycloalkyl bipyrrolidinylphenyl amide derivatives, preparation and therapeutic use thereof | |
| JPH0641068A (en) | Indoline derivative and composition for treating allergic or inflammatory disease | |
| WO1993003008A1 (en) | 5-aminosulfonanilide compound | |
| JPH01246274A (en) | Dihydrobenzofuranone derivative | |
| JPH07121935B2 (en) | Dihydrobenzofuranone derivative | |
| JPH07121932B2 (en) | Dihydrobenzofuranone derivative | |
| JP2686876B2 (en) | Novel succinic acid derivative | |
| JPS59139379A (en) | Pyridine derivative | |
| JP2802778B2 (en) | Homopiperazine derivatives and cerebral protective agents containing the same | |
| JPS58183652A (en) | (n-substituted cyclohexyloxyphenyl)-alpha-amino acid compound and lipid reducing agent containing said compound | |
| KR970011454B1 (en) | Novel amide compounds | |
| JPS63156771A (en) | 3-aminoindolin-2-one derivative | |
| JPH02138160A (en) | N-substituted amide compound |